TW201326124A - Plant growth regulating compounds - Google Patents
Plant growth regulating compounds Download PDFInfo
- Publication number
- TW201326124A TW201326124A TW101133662A TW101133662A TW201326124A TW 201326124 A TW201326124 A TW 201326124A TW 101133662 A TW101133662 A TW 101133662A TW 101133662 A TW101133662 A TW 101133662A TW 201326124 A TW201326124 A TW 201326124A
- Authority
- TW
- Taiwan
- Prior art keywords
- alkyl
- hydrogen
- cyano
- alkoxy
- haloalkyl
- Prior art date
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
本發明涉及新穎的非甾類的油菜素內酯(brassinosteroid)模擬物的衍生物、它們的製備方法與中間體、包含它們的植物生長調節劑組合物、以及將它們用於控制植物生長和/或促進種子萌發的方法。 The present invention relates to novel non-steroidal brassinosteroid mimetic derivatives, processes for their preparation and intermediates, plant growth regulator compositions comprising same, and their use for controlling plant growth and/or Or a method that promotes seed germination.
作用於油菜素內酯信號途徑的各種化學衍生物已經被描述於,例如,生物有機化學與醫藥化學(Bioorg.Med.Chem.,1998),6,p.1975;生物有機化學與醫藥化學通訊(Bioorg.Med.Chem.Lett.,1999),9,p.425;農業食品化學(J.Agric.Food Chem.,2002),50;p.3486;植物學(Planta,2001),213,p.716;WO2008/049729,WO2009/109570以及化學與生物學(Chemistry & Biology,2009),16,p.594-604中。油菜素內酯及其類似物已經描述了具有有用植物的生長調節特性。 Various chemical derivatives acting on the Brassinolide signaling pathway have been described, for example, in Bioorganic Chemistry and Medicinal Chemistry (Bioorg. Med. Chem., 1998) , 6, p. 1975; Bioorganic Chemistry and Medicinal Chemistry Newsletter (Bioorg. Med. Chem. Lett., 1999 ), 9, p. 425; Agro-Food Chemistry (J. Agric. Food Chem., 2002 ), 50; p. 3486; Botany (Planta, 2001 ), 213, P.716; WO 2008/049729, WO 2009/109570 and Chemistry & Biology, 2009 , 16, p. 594-604. Brassinolide and its analogs have been described to have growth-regulating properties of useful plants.
出人意料地,現在已經發現了某些新穎的非甾類的油菜素內酯模擬物的衍生物具有用於控制植物生長和/或促進種子萌發的有用的特性。較佳的是,該等新穎化合物可以導致改進的植物生長特性,例如更快的生長、更快的萌發、更早的萌發,和/或降低的毒性。該等化合物可以提供其他的優 點,例如,增強的溶解度,或是更利於配製的,提供到植物的更高效的輸送,提供改進的植物的攝入,或者是更容易生物可降解的。 Surprisingly, it has now been discovered that certain novel non-steroidal brassinolide mimetic derivatives have useful properties for controlling plant growth and/or promoting seed germination. Preferably, such novel compounds can result in improved plant growth characteristics such as faster growth, faster germination, earlier germination, and/or reduced toxicity. These compounds can provide other advantages Point, for example, enhanced solubility, or more formulation, provides for more efficient delivery to plants, provides improved plant intake, or is more biodegradable.
根據本發明,提供了式(I)的化合物
其中每個W獨立地是O或S;R1、R2、以及R9獨立地是H,C1-C6鹵烷基,C1-C6烷氧基,氰基,鹵素,C1-C6烷基或者由一或多個羥基、胺取代的C1-C6烷基;X係鹵素,C1-C6鹵烷基,氰基,硫氰酸酯,硝基,C1-C6烷氧基,C1-C6鹵烷氧基,C1-C6烷硫基,C1-C6鹵代烷硫基,C1-C6烷基亞磺醯基,C1-C6鹵烷基亞磺醯基,C1-C6烷基磺醯基,C1-C6鹵烷基磺醯基,C2-C6烯基,C2-C6炔基,胺,N-C1-C6烷基胺,N,N-二-C1-C6烷基胺,C1-C6烷基羰基,C1-C6烷氧基羰基,C1-C6鹵代烷氧基羰基,C1-C6鹵代烷基羰基,C3-C8環烷基,甲醯基、巰基;或者X係雜芳基或由一或多個鹵素、氰基、C1-C3烷基、C1-C3鹵烷基取代的雜芳基;並且條件係當X係鹵素時,R2、R3、R4、R5、R6、R7、R9係氫,兩個W都是氧,並且R8係氫、甲基、乙基、丙基或者由一或兩個的羥基、鹵素或胺取代的C2-C3烷基, 此外R1不是氫,C1-C2烷基,或者由一或兩個的鹵素、羥基或胺取代的C2烷基;R3係氫,C1-C6烷基,C1-C6鹵烷基,C1-C6烷基羰基、C1-C6烷氧基羰基;或者R3係由一或多個氰基、胺、羰基胺取代的C1-C6烷基;R4、R5、R6以及R7獨立地是氫、鹵素、硝基、氰基、C1-C6烷基、C1-C6鹵烷基、C1-C6烷氧基、羥基、-OC(O)R10、胺、N-C1-C6烷基胺或者N,N-二-C1-C6烷基胺;R8係氫,C1-C6烷基,C1-C6鹵烷基,C2-C6烯基,C2-C6鹵烯基,C2-C6炔基,C2-C6鹵炔基,C3-C6環烷基,C4-C6烷基環烷基,苄基或者由一至五個取代基R11取代的苄基,芳基或者由一至五個取代基R11取代的芳基,雜芳基或者由一至五個取代基R11取代的雜芳基,雜環基或者由一至五個取代基R11取代的雜環基;或者R8係由一或多個以下者取代的C1-C6烷基:氰基,硝基,胺,N-C1-C6烷基胺,N,N-二-C1-C6烷基胺,羥基,C1-C6烷氧基,C1-C6鹵烷氧基,C1-C6烷硫基,C1-C6鹵烷硫基,C1-C6烷基亞磺醯基,C1-C6鹵烷基亞磺醯基,C1-C6烷基磺醯基,C1-C6鹵烷基磺醯基,苄基或者由一至五個取代基R11取代的苄基,芳基或者由一至五個取代基R11取代的芳基,雜芳基或者由一至五個取代基R11取代的雜芳基,雜環基或者由一至五個取代基R11取代的雜環基;R10係氫,C1-C6烷基,C1-C6烷氧基或者C1-C6鹵烷基;並且每個R11獨立地是氰基,硝基,胺,羥基,鹵素,C1-C6烷基,C1-C6鹵烷基,C1-C4烷氧基-C1-C4烷基,C2-C6烯基,C2-C6鹵烯基,C2-C6炔基,C2-C6鹵炔基,C3-C6環烷基,C3-C6鹵環烷基,C1-C6烷氧基,C1-C6鹵烷氧基,C1-C4 烷氧基-C1-C4烷氧基,C1-C6烷硫基,C1-C6鹵烷硫基,C1-C6烷基亞磺醯基,C1-C6鹵烷基亞磺醯基,C1-C6烷基磺醯基,C1-C6鹵烷基磺醯基,N-C1-C6烷胺基,N,N-二-(C1-C6烷基)-胺基,N,N-二-(C1-C6烷基)-胺基羰基,N,N-二-(C1-C6烷基)-胺基磺醯基,C1-C6烷基羰基,C1-C6烷基羰基氧基,C1-C6烷氧基羰基,C1-C6烷基羰基胺基;或者其鹽或N-氧化物;並且不包括下列化合物,其中X係三氟甲基,R1係氯,R2、R3、R4、R5、R6、R7、R8、R9係氫,並且兩個W都是氧;X係氯或者溴,R1、R2、R3、R5、R6、R7、R8、R9係氫,R4係胺,並且兩個W都是氧;X係碘或者溴,R1、R3、R4、R5、R6、R7、R9係氫,R2與R8係甲基,並且兩個W都是氧;X係溴,R1、R2、R4、R5、R6、R7、R9係氫,R3係乙基,R8係甲基,並且兩個W都是氧;並且X係硝基、N-C1-C6烷基胺或者N,N-二-C1-C6烷基胺,R1、R2、R3、R4、R5、R6、R7、R8、R9係氫,並且兩個W都是氧。 Wherein each W is independently O or S; R 1 , R 2 , and R 9 are independently H, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, cyano, halo, C 1 -C 6 alkyl or C 1 -C 6 alkyl substituted by one or more hydroxyl or amine; X-based halogen, C 1 -C 6 haloalkyl, cyano, thiocyanate, nitro, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 alkylthio, C 1 -C 6 haloalkylthio, C 1 -C 6 alkylsulfinyl, C 1 - C 6 haloalkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkylsulfonyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, amine , NC 1 -C 6 alkylamine, N,N-di-C 1 -C 6 alkylamine, C 1 -C 6 alkylcarbonyl, C 1 -C 6 alkoxycarbonyl, C 1 -C 6 haloalkane Oxycarbonyl, C 1 -C 6 haloalkylcarbonyl, C 3 -C 8 cycloalkyl, indolyl, fluorenyl; or X-based heteroaryl or consisting of one or more halogens, cyano, C 1 -C 3 An alkyl group, a C 1 -C 3 haloalkyl substituted heteroaryl group; and the condition is that when X is a halogen, R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 are hydrogen, two Each of W is oxygen, and R 8 is hydrogen, methyl, ethyl, propyl or hydroxy by one or two a C 2 -C 3 alkyl group substituted with a halogen or an amine, further R 1 is not hydrogen, C 1 -C 2 alkyl, or a C 2 alkyl group substituted by one or two halogen, hydroxy or amine; R 3 Hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkylcarbonyl, C 1 -C 6 alkoxycarbonyl; or R 3 consists of one or more cyano Amine, carbonylamine substituted C 1 -C 6 alkyl; R 4 , R 5 , R 6 and R 7 are independently hydrogen, halogen, nitro, cyano, C 1 -C 6 alkyl, C 1 - C 6 haloalkyl, C 1 -C 6 alkoxy, hydroxy, -OC(O)R 10 , amine, NC 1 -C 6 alkylamine or N,N-di-C 1 -C 6 alkylamine R 8 is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl, C 3 -C 6 cycloalkyl, C 4 -C 6 alkylcycloalkyl, benzyl or benzyl substituted by one to five substituents R 11 , aryl or from one to five substituent group R 11 substituted aryl, heteroaryl or by one to five substituents R 11 substituted aryl, heteroaryl, or heterocyclyl group by one to five substituents R 11 substituted heterocyclic group; or R 8 by a line one or more of the following are substituted with the C 1 -C 6 Group: cyano, nitro, amine, NC 1 -C 6 alkylamine, N, N- two -C 1 -C 6 alkylamine, hydroxy, C 1 -C 6 alkoxy, C 1 -C 6 Haloalkoxy, C 1 -C 6 alkylthio, C 1 -C 6 haloalkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 haloalkylsulfinyl, C 1- C 6 alkylsulfonyl, C 1 -C 6 haloalkylsulfonyl, benzyl or benzyl substituted by one to five substituents R 11 , aryl or substituted by one to five substituents R 11 Aryl, heteroaryl or heteroaryl substituted by one to five substituents R 11 , heterocyclyl or heterocyclyl substituted by one to five substituents R 11 ; R 10 is hydrogen, C 1 -C 6 An alkyl group, a C 1 -C 6 alkoxy group or a C 1 -C 6 haloalkyl group; and each R 11 is independently a cyano group, a nitro group, an amine group, a hydroxyl group, a halogen group, a C 1 -C 6 alkyl group, C 1- C 6 haloalkyl, C 1 -C 4 alkoxy-C 1 -C 4 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 halocycloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 - C 4 alkoxy-C 1 -C 4 alkoxy, C 1 -C 6 alkylthio, C 1 -C 6 haloalkylthio, C 1 -C 6 Alkylsulfinyl, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkylsulfonyl, N -C 1 -C 6 Alkylamino, N , N -di-(C 1 -C 6 alkyl)-amino, N , N -di-(C 1 -C 6 alkyl)-aminocarbonyl, N , N -di-( C 1 -C 6 alkyl)-aminosulfonyl, C 1 -C 6 alkylcarbonyl, C 1 -C 6 alkylcarbonyloxy, C 1 -C 6 alkoxycarbonyl, C 1 -C 6 An alkylcarbonylamino group; or a salt or N-oxide thereof; and does not include the following compounds, wherein X is a trifluoromethyl group, R 1 is a chlorine group, R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 are hydrogen, and both W are oxygen; X is chlorine or bromine, and R 1 , R 2 , R 3 , R 5 , R 6 , R 7 , R 8 , R 9 are hydrogen, R 4 is an amine, and both W are oxygen; X is iodine or bromine, R 1 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 are hydrogen, and R 2 and R 8 are methyl. And both W are oxygen; X is bromine, R 1 , R 2 , R 4 , R 5 , R 6 , R 7 , R 9 are hydrogen, R 3 is ethyl, R 8 is methyl, and two Each of W is oxygen; and X is a nitro group, an NC 1 -C 6 alkylamine or an N,N-di-C 1 -C 6 alkylamine, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are hydrogen, and both W are oxygen.
根據式(I’)的化合物可以用在植物生長調節劑或者種子萌發促進劑組合物中或者用作植物生長調節劑或者種子萌發促進劑,其中式(I)係與式(I)相同的,但是僅在下列的條件下當X係鹵素時,R2、R3、R4、R5、R6、R7、R9係氫,兩個W都是氧,並且R8係氫、甲基、乙基、丙基或者由一或兩個的羥基、鹵素或胺取代的C2-C3 烷基,此外R1不是氫、C1-C2烷基或者由一或兩個的鹵素、羥基或胺取代的C2烷基;並且不包括下列化合物,其中X係硝基,R1、R2、R3、R4、R5、R6、R7、R8、R9係氫,並且兩個W都是氧。 The compound according to formula (I') can be used in a plant growth regulator or seed germination promoter composition or as a plant growth regulator or a seed germination promoter, wherein formula (I) is the same as formula (I), However, when X is halogen under the following conditions, R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 9 are hydrogen, both W are oxygen, and R 8 is hydrogen, A a C 2 -C 3 alkyl group substituted by one or two hydroxyl groups, halogens or amines, in addition R 1 is not hydrogen, C 1 -C 2 alkyl or one or two halogens a hydroxyl or amine substituted C 2 alkyl group; and does not include the following compounds, wherein X is a nitro group, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 are Hydrogen, and both W are oxygen.
下列化合物因此包含在式(I’)中:X係三氟甲基,R1係氯,R2、R3、R4、R5、R6、R7、R8、R9係氫,並且兩個W都是氧;X係氯或者溴,R1、R2、R3、R5、R6、R7、R8、R9係氫,R4係胺,並且兩個W都是氧;X係碘或者溴,R1、R3、R4、R5、R6、R7、R9係氫,R2與R8係甲基,並且兩個W都是氧;X係溴,R1、R2、R4、R5、R6、R7、R9係氫,R3係乙基,R8係甲基,並且兩個W都是氧;並且X係N-C1-C6烷基胺或者N,N-二-C1-C6烷基胺,R1、R2、R3、R4、R5、R6、R7、R8、R9係氫,並且兩個W都是氧。 The following compounds are therefore included in formula (I'): X-based trifluoromethyl, R 1 is chlorine, R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 are hydrogen, And both W are oxygen; X is chlorine or bromine, R 1 , R 2 , R 3 , R 5 , R 6 , R 7 , R 8 , R 9 are hydrogen, R 4 is amine, and both W are Is oxygen; X is iodine or bromine, R 1 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 are hydrogen, R 2 and R 8 are methyl, and both W are oxygen; Is bromine, R 1 , R 2 , R 4 , R 5 , R 6 , R 7 , R 9 are hydrogen, R 3 is ethyl, R 8 is methyl, and both W are oxygen; and X-based NC 1- C 6 alkylamine or N,N-di-C 1 -C 6 alkylamine, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 Hydrogen, and both W are oxygen.
在式(I)與式(I’)的另外的實施方式中,當X係鹵素時,R1不是氫、C1-C2烷基或者由一或多個的鹵素、羥基或胺取代的C2烷基。 In a further embodiment of formula (I) and formula (I'), when X is halogen, R 1 is not hydrogen, C 1 -C 2 alkyl or substituted by one or more halogen, hydroxy or amine C 2 alkyl.
式(I)或(I’)的化合物能以不同的幾何或光學異構體(非對映異構體以及對映異構體)或互變異構的形式存在。本發明涵蓋了所有的此類異構體以及互變異構體以及它們的處於所有比例的混合物,連同同位素形式,例如氘化的化合物。本發明還涵蓋了式(I)或(I’)的化合物的所有的鹽、N-氧化 物、以及類金屬的鍺合物。 The compounds of formula (I) or (I') can exist in different geometric or optical isomers (diastereomers and enantiomers) or tautomeric forms. The present invention encompasses all such isomers as well as tautomers and mixtures thereof in all ratios, along with isotopic forms, such as deuterated compounds. The invention also encompasses all salts, N-oxidation of compounds of formula (I) or (I') And metal-like compounds.
每個烷基部分(moiety)單獨的或者作為更大的基團的一部分(例如烷氧基、烷氧基羰基、烷基羰基、烷胺基羰基、二烷胺基羰基)係直鏈的或支鏈的,並且是例如甲基、乙基、正丙基、正丁基、正戊基、正己基、異丙基、正丁基、仲丁基、異丁基、三級丁基或新戊基。該等烷基較佳的是C1至C6烷基,更佳的是C1-C4並且最佳的是C1-C3烷基。 Each alkyl moiety is linear or as part of a larger group (eg, alkoxy, alkoxycarbonyl, alkylcarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl) or Branched and is, for example, methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl or new Amyl. The alkyl groups are preferably a C 1 to C 6 alkyl group, more preferably C 1 - C 4 and most preferably a C 1 - C 3 alkyl group.
每個烯基部分單獨的或者作為更大的基團的一部分(例如烷氧基、烷氧基羰基、烷基羰基、烷胺基羰基、二烷胺基羰基)具有至少一個碳碳雙鍵,並且是例如乙烯基、烯丙基。該等烯基較佳的是C2至C6烯基,更佳的是C2-C4烯基。 Each alkenyl moiety has at least one carbon-carbon double bond, either alone or as part of a larger group (eg, alkoxy, alkoxycarbonyl, alkylcarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl). Also, for example, a vinyl group or an allyl group. The alkenyl group is preferably a C 2 to C 6 alkenyl group, more preferably a C 2 -C 4 alkenyl group.
每個炔基部分單獨的或者作為更大的基團的一部分(例如烷氧基、烷氧基羰基、烷基羰基、烷胺基羰基、二烷胺基羰基)具有至少一個碳碳三鍵,並且是例如乙炔基、炔丙基。該等炔基較佳的是C2至C6炔基,更佳的是C2-C4炔基。如在此使用的,術語“炔基”,除非另外指明,包括具有至少一個碳碳三鍵的烷基部分(moiety),其中,烷基係如上定義的。 Each alkynyl moiety has at least one carbon-carbon triple bond, either alone or as part of a larger group (eg, alkoxy, alkoxycarbonyl, alkylcarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl). And is, for example, an ethynyl group or a propargyl group. The alkynyl groups are preferably a C 2 to C 6 alkynyl group, more preferably a C 2 -C 4 alkynyl group. As used herein, the term "alkynyl", unless otherwise indicated, includes alkyl moieties having at least one carbon-carbon triple bond, wherein alkyl is as defined above.
鹵素係氟、氯、溴、或碘。 Halogen is fluorine, chlorine, bromine, or iodine.
鹵烷基(單獨的或者作為更大的基團如鹵代烷氧基或鹵代烷硫基的一部分)係被一或多個相同或不同的鹵素原子取代的烷基,並且是例如-CF3、-CF2Cl、-CH2CF3或-CH2CHF2。 Haloalkyl (either alone or as a larger group, such as haloalkoxy or haloalkylthio portion) is based one or more identical or different halogen atoms, substituted alkyl group, and is, for example -CF 3, -CF 2 Cl, -CH 2 CF 3 or -CH 2 CHF 2 .
羥烷基係由一或多個羥基取代的烷基,並且是例如-CH2OH、-CH2CH2OH或者-CH(OH)CH3。 The hydroxyalkyl group is an alkyl group substituted by one or more hydroxy groups, and is, for example, -CH 2 OH, -CH 2 CH 2 OH or -CH(OH)CH 3 .
在本說明書的上下文中術語“芳基”指可以是單環、雙環或三環的環 系統。此類環的例子包括苯基、萘基、蒽基、茚基或菲基。較佳的芳基基團係苯基。 The term "aryl" in the context of the present specification refers to a ring which may be monocyclic, bicyclic or tricyclic system. Examples of such rings include phenyl, naphthyl, anthracenyl, fluorenyl or phenanthryl. Preferred aryl groups are phenyl groups.
除非另外指明,烯基以及炔基,它們自己或者作為另一取代基的一部分,可以是直鏈的或者支鏈的,並且較佳的是包含2到6個碳原子,較佳的是2到4個,更佳的是2到3個,並且適當時,可以是處於(E)-或者(Z)-組態的。實例包括乙烯基、烯丙基以及炔丙基。 Unless otherwise indicated, alkenyl and alkynyl, either by themselves or as part of another substituent, may be straight or branched, and preferably contain from 2 to 6 carbon atoms, preferably 2 to 4, more preferably 2 to 3, and if appropriate, can be in ( E )- or ( Z )-configuration. Examples include vinyl, allyl, and propargyl.
除非另外指明,環烷基可以是單環或雙環的,可以是由一或多個C1-C6烷基可任選取代的,並且較佳的是包含3至7個碳原子,更佳的是3至6個碳原子。環烷基的實例包括環丙基、1-甲基環丙基、2-甲基環丙基、環丁基、環戊基以及環己基。 Unless otherwise specified, a cycloalkyl group may be monocyclic or bicyclic, and may be optionally substituted by one or more C 1 -C 6 alkyl groups, and preferably contains 3 to 7 carbon atoms, more preferably It is 3 to 6 carbon atoms. Examples of the cycloalkyl group include a cyclopropyl group, a 1-methylcyclopropyl group, a 2-methylcyclopropyl group, a cyclobutyl group, a cyclopentyl group, and a cyclohexyl group.
每個W獨立地是O或S。較佳的是兩個W係相同的。更佳的是兩個W都是O。 Each W is independently O or S. Preferably, the two W systems are identical. More preferably, both W are O.
術語“雜芳基”指芳環系統,該芳環系統包括至少一個雜原子並且由單環或兩個或更多個稠和的環組成。較佳的是,單環包括至多三個雜原子並且雙環系統包括至多四個雜原子,該等雜原子較佳的是選自氮、氧和硫。此類基團的實例包括吡啶基、嗒基、嘧啶基、吡基、呋喃基、苯硫基、唑基、異唑基、二唑基、噻唑基、異噻唑基、噻二唑基、吡咯基、吡唑基、咪唑基、三唑基以及四唑基。較佳的雜芳基係吡啶。 The term "heteroaryl" refers to an aromatic ring system comprising at least one heteroatom and consisting of a single ring or two or more fused rings. Preferably, the monocyclic ring comprises up to three heteroatoms and the bicyclic system comprises up to four heteroatoms, preferably selected from the group consisting of nitrogen, oxygen and sulfur. Examples of such groups include pyridyl, anthracene Base, pyrimidinyl, pyridyl Base, furanyl, phenylthio, Azolyl, different Azolyl, A oxazolyl group, a thiazolyl group, an isothiazolyl group, a thiadiazolyl group, a pyrrolyl group, a pyrazolyl group, an imidazolyl group, a triazolyl group, and a tetrazolyl group. Preferred heteroaryl pyridines.
術語“雜環基”被定義為包括雜芳基以及此外的它們的不飽和的或部分不飽和的類似物,例如4,5,6,7-四氫苯并苯硫基、9H-茀基、3,4-二氫-2H-苯并-1,4-二氧雜環庚烯基、2,3-二氫-苯并呋喃基、哌啶基、1,3-二氧戊環基、1,3-二氧雜環己基、4,5-二氫異唑基、四氫呋喃基以及啉基。 The term "heterocyclyl" is defined to include heteroaryl and, in addition, their unsaturated or partially unsaturated analogs, such as 4,5,6,7-tetrahydrobenzophenylthio, 9H-fluorenyl. , 3,4-dihydro-2H-benzo-1,4-dioxanthyl, 2,3-dihydro-benzofuranyl, piperidinyl, 1,3-dioxolanyl , 1,3-dioxanyl, 4,5-dihydroiso Azolyl, tetrahydrofuranyl and Alkyl group.
式I的化合物中的W、R1、R2、R3、R4、R5、R6、R7、R8、R9以及X較佳的值係處於任何組合的形式,如以下提出的:兩個W都是O;R1係H、三氟甲基、氰基、鹵素或者甲基;R2係H、三氟甲基、氰基、甲氧基、鹵素或者甲基;X係C1-C6鹵烷基或者氰基;R3係H或C1-C6烷基;R4、R5、R6和R7各自獨立地是氫或甲基;R8係氫,C1-C6烷基,C1-C6鹵烷基,C2-C6烯基,C2-C6炔基,或者R8係由一或多個C1-C6烷氧基、C1-C6烷硫基取代的C1-C6烷基;並且R9係氫,C1-C6烷基,C1-C6烷氧基或者鹵素。 Preferred values for W, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and X in the compounds of formula I are in any combination, as set forth below : Both W are O; R 1 is H, trifluoromethyl, cyano, halogen or methyl; R 2 is H, trifluoromethyl, cyano, methoxy, halogen or methyl; Is a C 1 -C 6 haloalkyl or cyano group; R 3 is H or C 1 -C 6 alkyl; R 4 , R 5 , R 6 and R 7 are each independently hydrogen or methyl; R 8 is hydrogen , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, or R 8 is derived from one or more C 1 -C 6 alkoxy a C 1 -C 6 alkylthio substituted C 1 -C 6 alkyl group; and R 9 is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy or halogen.
更佳的是,R1係H或者甲基。特別地,R1係H。 More preferably, R 1 is H or methyl. In particular, R 1 is H.
更佳的是,R2係H。 More preferably, R 2 is H.
更佳的是,X係三氟甲基或者氰基。特別地,X係三氟甲基。特別地,X係氰基。 More preferably, X is a trifluoromethyl group or a cyano group. In particular, X is a trifluoromethyl group. In particular, X-based cyano group.
更佳的是,R3係H。 More preferably, R 3 is H.
較佳的是,R8係氫、甲基、乙基、正丙基或者異丙基。更佳的是,R8係氫、甲基、或乙基。特別地,R8係氫或者甲基。 Preferably, R 8 is hydrogen, methyl, ethyl, n-propyl or isopropyl. More preferably, R 8 is hydrogen, methyl or ethyl. In particular, R 8 is hydrogen or methyl.
更佳的是,R9係H。 More preferably, R 9 is H.
特別地,R4、R5、R6以及R7係H。 In particular, R 4 , R 5 , R 6 and R 7 are H.
下面的表1包含了式(I)的化合物的實例,其中,W係氧,並且R1、R2、 R3、R4、R5、R6、R7、R8、R9以及X係如定義的。 Table 1 below contains examples of compounds of formula (I) wherein W is oxygen and R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and X As defined.
根據本發明的式I的化合物可以自身被用作植物生長調節劑或者種子 萌發促進劑,但是它們通常使用配製物佐劑(例如載體、溶劑以及表面活性劑(SFA))配製成植物生長調節或種子萌發促進組合物中。因此,本發明進一步提供了植物生長調節劑組合物,包括在此描述的植物生長調節化合物以及農業上可接受的配製物佐劑或載體。本發明進一步提供了種子萌發促進劑組合物,包括在此描述的種子萌發促進劑化合物以及農業上可接受的配製物佐劑或載體。較佳的是,該組合物主要由式I的化合物以及農業上可接受的配製物佐劑或載體組成。在替代方案中,該組合物由式I的化合物以及至少一種農業上可接受的配製物佐劑或載體組成。在一實施方式中,本發明提供了包含式I的化合物以及農業上可接受的載體的組合物,其中在式I中,W係O;R1係H,三氟甲基,氰基,鹵素或者甲基;R2係H,甲氧基,三氟甲基,氰基,鹵素或者甲基;X係C1-C6鹵烷基或者氰基;R3係H或者C1-C6烷基;R4、R5、R6、以及R7各自獨立地是氫或甲基;R8係氫,C1-C6烷基,C1-C6鹵烷基,C2-C6烯基,C2-C6炔基,或者R8係由至少一個C1-C6烷氧基、C1-C6烷硫基取代的C1-C6烷基;並且R9係氫。 The compounds of formula I according to the invention may themselves be used as plant growth regulators or seed germination promoters, but they are usually formulated with plant adjuvants using formulation adjuvants such as carriers, solvents and surfactants (SFA). Or seed germination promotes the composition. Accordingly, the present invention further provides plant growth regulator compositions comprising the plant growth regulating compounds described herein and an agriculturally acceptable formulation adjuvant or carrier. The invention further provides a seed germination promoter composition comprising the seed germination promoter compound described herein and an agriculturally acceptable formulation adjuvant or carrier. Preferably, the composition consists essentially of a compound of formula I and an agriculturally acceptable formulation adjuvant or carrier. In the alternative, the composition consists of a compound of formula I and at least one agriculturally acceptable formulation adjuvant or carrier. In one embodiment, the invention provides a composition comprising a compound of formula I and an agriculturally acceptable carrier, wherein in formula I, W is O; R 1 is H, trifluoromethyl, cyano, halogen Or methyl; R 2 is H, methoxy, trifluoromethyl, cyano, halogen or methyl; X-based C 1 -C 6 haloalkyl or cyano; R 3 H or C 1 -C 6 Alkyl; R 4 , R 5 , R 6 , and R 7 are each independently hydrogen or methyl; R 8 is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl group, or R 8 lines by at least one C 1 -C 6 alkoxy, C 1 -C 6 alkylthio-substituted C 1 -C 6 alkyl; and R 9 lines hydrogen.
在另一實施方式中,本發明提供了的包含式I的化合物以及農業上可接受的載體的組合物,其中在式I中,W係O;R1係H或者甲基;R2係H;X係三氟甲基或者氰基;R3係H;R4、R5、R6、以及R7各自獨立地是氫或甲基;R8係氫,或者甲基;並且R9係氫。 In another embodiment, the present invention provides a composition comprising a compound and an agriculturally acceptable carrier comprising a formula I, wherein in formula I, W-based O; R 1 Department H or methyl; R 2 lines H X-based trifluoromethyl or cyano; R 3 H; R 4 , R 5 , R 6 , and R 7 are each independently hydrogen or methyl; R 8 is hydrogen or methyl; and R 9 is hydrogen.
該組合物可以按在使用前稀釋的濃縮物的形式存在,雖然還可以製成即用的組合物。通常用水進行最終稀釋,但是可以取代水,或者除了水,還可以使用例如液體肥料、微量營養素、生物有機體、油或溶劑。 The composition may be in the form of a concentrate that is diluted prior to use, although it may also be formulated as a ready-to-use composition. The final dilution is usually carried out with water, but water may be substituted, or in addition to water, for example, liquid fertilizers, micronutrients, biological organisms, oils or solvents may be used.
該組合物通常包括按重量計從0.1%到99%的,尤其是按重量計從0.1% 到95%的式I的化合物以及按重量計從1%到99.9%的配製物佐劑,該配製物佐劑較佳的是包括按重量計從0到25%的表面活性物質。 The composition typically comprises from 0.1% to 99% by weight, especially from 0.1% by weight. To 95% of the compound of formula I and from 1% to 99.9% by weight of the formulation adjuvant, the formulation adjuvant preferably comprises from 0 to 25% by weight of surface active material.
該等組合物可以選自多種配製物類型,其中很多從Manual on Development and Use of FAO Specifications for Plant Protection Products(關於植物保護產品的FAO標準的發展和使用的手冊),第5版,1999年中得知。該等包括可撒性粉劑(DP)、可溶性粉劑(SP)、水溶顆粒(SG)、水可分散的顆粒(WG)、可濕性粉劑(WP)、顆粒(GR)(慢或快釋的)、可溶的濃縮物(SL)、油可混溶的液體(OL)、超低體積液體(UL)、可乳化的濃縮物(EC)、可分散的濃縮物(DC)、乳液(水包油(EW)和油包水(EO)兩者)、微乳液(ME)、懸浮體濃縮物(SC)、氣溶膠、膠囊懸浮液(CS)以及種子處理的配製物。在任何情況下,所選擇的配製物類型將取決於所打算的具體目的以及式(I)或(I’)的化合物的物理、化學和生物學特性。 The compositions may be selected from a variety of formulation types, many of which are from Manual on Development and Use of FAO Specifications for Plant Protection Products, 5th Edition, 1999 Learned. These include spreadable powder (DP), soluble powder (SP), water soluble particles (SG), water dispersible granules (WG), wettable powders (WP), granules (GR) (slow or fast release) ), soluble concentrate (SL), oil-miscible liquid (OL), ultra-low volume liquid (UL), emulsifiable concentrate (EC), dispersible concentrate (DC), emulsion (water) Formulations of both oil-in-oil (EW) and water-in-oil (EO), microemulsion (ME), suspension concentrate (SC), aerosol, capsule suspension (CS), and seed treatment. In any event, the type of formulation selected will depend on the particular purpose intended and the physical, chemical and biological properties of the compound of formula (I) or (I').
可灑性粉劑(DP)可藉由將式(I)或(I’)的化合物與一或多種固體稀釋劑(例如,天然粘土、高嶺土、葉蠟石、膨潤土、氧化鋁、蒙脫石、矽藻土(kieselguhr)、白堊土、矽藻土(diatomaceous earths)、磷酸鈣、碳酸鈣和碳酸鎂、硫、石灰、麵粉、滑石和其他有機和無機的固體載體)混合並將該混合物機械地碾磨成細粉末來製備。 A sprinkable powder (DP) can be obtained by combining a compound of formula (I) or (I') with one or more solid diluents (for example, natural clay, kaolin, pyrophyllite, bentonite, alumina, montmorillonite, Mixing kieselguhr, chalk soil, diatomaceous earths, calcium phosphate, calcium carbonate and magnesium carbonate, sulfur, lime, flour, talc and other organic and inorganic solid carriers and mechanically mixing the mixture It is prepared by milling into a fine powder.
可溶性粉劑(SP)可以藉由將式(I)或(I’)的化合物與一或多種水溶性無機鹽(如碳酸氫鈉、碳酸鈉或硫酸鎂)或一或多種水溶性有機固體(如多糖)以及,可任選地,一或多種潤濕劑、一或多種分散劑或所述試劑的混合物進行混合來製備以改進水分散性/水溶性。然後將該混合物研磨成細粉末。也可以將類似的組合物顆粒化以形成水溶性顆粒(SG)。 The soluble powder (SP) may be obtained by reacting a compound of formula (I) or (I') with one or more water-soluble inorganic salts (such as sodium hydrogencarbonate, sodium carbonate or magnesium sulfate) or one or more water-soluble organic solids (such as Polysaccharides) and, optionally, one or more wetting agents, one or more dispersing agents, or a mixture of such agents are prepared to improve water dispersibility/water solubility. The mixture was then ground to a fine powder. Similar compositions can also be granulated to form water soluble particles (SG).
可濕性粉劑(WP)可以藉由將式(I)或(I’)的化合物與一或多種固體稀釋劑或載體、一或多種濕潤劑以及,較佳的是,一或多種分散劑,以及,可任選地,一或多種的懸浮劑混合來製備以促進在液體中的分散。然後將該混合物研磨成細粉末。也可以將類似的組合物顆粒化以形成水可分散的顆粒(WG)。 Wettable powder (WP) may be obtained by combining a compound of formula (I) or (I') with one or more solid diluents or carriers, one or more wetting agents, and, preferably, one or more dispersing agents, And, optionally, one or more suspending agents are mixed to prepare to promote dispersion in the liquid. The mixture was then ground to a fine powder. Similar compositions can also be granulated to form water dispersible granules (WG).
可以這樣形成顆粒(GR):藉由將式(I)或(I’)的化合物與一或多種粉狀固體稀釋劑或載體的混合物顆粒化來形成,或者藉由將式(I)或(I’)的化合物(或其在適宜試劑中的溶液)吸收進多孔顆粒材料(例如浮石、凹凸棒石粘土、漂白土、矽藻土(kieselguhr)、矽藻土(diatomaceous earths)或玉米芯粉),或者藉由將式(I)的化合物(或其在適宜試劑中的溶液)吸附到硬芯材料(例如沙、矽酸鹽、礦物碳酸鹽、硫酸鹽或磷酸鹽)上並且如果必要的話,進行乾燥來由預成型的空白顆粒形成。通常用來幫助吸收或吸附的試劑包括溶劑(例如脂肪族和芳香族的石油溶劑、醇、醚、酮和酯)以及粘著劑(例如聚乙酸乙烯酯、聚乙烯醇、糊精、糖和植物油)。也可以在顆粒中包括一或多種其他添加劑(例如乳化劑、濕潤劑或分散劑)。 Granules (GR) may be formed by granulating a mixture of a compound of formula (I) or (I') with one or more powdered solid diluents or carriers, or by formula (I) or The compound of I') (or its solution in a suitable reagent) is absorbed into a porous particulate material (eg, pumice, attapulgite clay, fuller's earth, kieselguhr, diatomaceous earths, or corncob powder) Or by adsorbing a compound of formula (I) (or a solution thereof in a suitable reagent) onto a hard core material (such as sand, citrate, mineral carbonate, sulfate or phosphate) and if necessary Drying is formed from preformed blank particles. Agents commonly used to aid absorption or adsorption include solvents (eg, aliphatic and aromatic petroleum solvents, alcohols, ethers, ketones, and esters) as well as adhesives (eg, polyvinyl acetate, polyvinyl alcohol, dextrin, sugar, and Vegetable oil). It is also possible to include one or more other additives (such as emulsifiers, wetting agents or dispersing agents) in the granules.
可分散的濃縮物(DC)可以藉由將式(I)或(I’)的化合物溶於水或有機溶劑例如酮、醇或乙二醇醚中來製備。該等溶劑可以包含表面活性劑(例如用來在噴霧槽中改進水稀釋性或防止結晶)。 Dispersible concentrates (DC) can be prepared by dissolving a compound of formula (I) or (I') in water or an organic solvent such as a ketone, alcohol or glycol ether. The solvents may comprise a surfactant (for example to improve water dilution or prevent crystallization in a spray tank).
可乳化的濃縮物(EC)或水包油乳液(EW)可以藉由將式(I)或(I)的化合物溶於有機溶劑(任選地包含一或多種濕潤劑、一或多種乳化劑或者所述試劑的混合物)中來製備。在EC中使用的合適的有機溶劑包括芳族烴(例如烷基苯或烷基萘,例如SOLVESSO 100、SOLVESSO 150和SOLVESSO 200;SOLVESSO係註冊商標)、酮(例如環己酮或甲基環己酮)和醇(例如苯甲醇、糠基醇或丁醇)、N-烷基吡咯啶酮(例如N-甲基吡咯啶酮或N-辛基吡咯啶酮)、脂肪酸的二甲基醯胺(例如C8-C10脂肪酸二甲基醯胺)和氯代烴。EC產品可以在加入水中時自發地乳化,產生具有足夠穩定性以便允許藉由適當設備噴霧施用的乳液。 An emulsifiable concentrate (EC) or an oil-in-water emulsion (EW) may be dissolved in an organic solvent (optionally comprising one or more wetting agents, one or more emulsifiers) by dissolving a compound of formula (I) or (I) Or prepared by mixing the reagents). Suitable organic solvents for use in the EC include aromatic hydrocarbons such as alkylbenzenes or alkylnaphthalenes such as SOLVESSO 100, SOLVESSO 150 and SOLVESSO 200; registered trademarks of SOLVESSO, ketones such as cyclohexanone or methylcyclohexane. Ketones and alcohols (such as benzyl alcohol, mercapto or butanol), N-alkylpyrrolidone (such as N-methylpyrrolidone or N-octylpyrrolidone), dimethyl decylamine of fatty acids (e.g., C 8 -C 10 fatty acid dimethyl decylamine) and chlorinated hydrocarbons. The EC product can be emulsified spontaneously upon addition to water, resulting in an emulsion that is sufficiently stable to allow for application by spraying with a suitable device.
EW的製備涉及獲得作為液體(如果它在室溫下不是液體,則它可以在典型地低於70℃的合理溫度下被熔化)或處於溶液中(藉由將它溶於合適的溶劑)的式(I)或(I’)的化合物,並且然後在高剪切下將所得液體或溶液乳化進包含一或多種SEA的水中,以產生乳液。在EW中使用的合適的溶劑包括植物油、氯代烴(例如氯苯)、芳香族溶劑(例如烷基苯或烷基萘)及其他在水中具有低溶解度的合適的有機溶劑。 The preparation of EW involves obtaining as a liquid (if it is not a liquid at room temperature, it can be melted at a reasonable temperature typically below 70 ° C) or in solution (by dissolving it in a suitable solvent) A compound of formula (I) or (I'), and then the resulting liquid or solution is emulsified under high shear into water containing one or more SEA to produce an emulsion. Suitable solvents for use in EW include vegetable oils, chlorinated hydrocarbons (e.g., chlorobenzene), aromatic solvents (e.g., alkylbenzenes or alkylnaphthalenes), and other suitable organic solvents having low solubility in water.
微乳液(ME)可以藉由將水與一或多種溶劑和一或多種SFA的摻合物混合來製備,以自發地產生熱力學穩定的各向同性的液體配製物。式(I)或(I’)的化合物一開始就存在於水中或溶劑/SFA摻合物中。適用於ME的溶劑包括以上所述用於EC或EW中的那些。ME可以是水包油體系或油包水體系(存在哪種體系可以藉由傳導率測試來測定)並且可以適用於在同一配製物中混合水溶性的和油溶性的殺有害生物劑。ME適於稀釋進入水中,保持為微乳液或者形成常規的水包油乳液。 Microemulsions (ME) can be prepared by mixing water with a blend of one or more solvents and one or more SFAs to spontaneously produce a thermodynamically stable isotropic liquid formulation. The compound of formula (I) or (I') is initially present in water or in a solvent/SFA blend. Solvents suitable for use in ME include those described above for use in EC or EW. The ME can be an oil-in-water system or a water-in-oil system (which system can be determined by conductivity testing) and can be adapted to mix water-soluble and oil-soluble pesticides in the same formulation. The ME is suitable for dilution into water, remaining as a microemulsion or forming a conventional oil-in-water emulsion.
懸浮體濃縮物(SC)可以包含式(I)或(I’)的化合物的細分散的不溶固體顆粒的水性或非水性懸浮液。SC可以任選地使用一或多種分散劑藉由在適宜介質中球磨或珠磨式(I)或(I’)的固體化合物來製備,以產生該化合物的細顆粒懸浮液。在該組合物中可以包括一或多種濕潤劑,並且可以包括懸 浮劑以降低顆粒的沈降速度。可替代地,可以將式(I)或(I’)的化合物乾磨並將其加入包含以上所述試劑的水中,以產生所希望的最終產品。 The suspension concentrate (SC) may comprise an aqueous or non-aqueous suspension of finely divided insoluble solid particles of the compound of formula (I) or (I'). SC may optionally be prepared by ball milling or bead milling of a solid compound of formula (I) or (I') using one or more dispersing agents to produce a fine particle suspension of the compound. One or more humectants may be included in the composition and may include suspension A floater to reduce the settling velocity of the particles. Alternatively, the compound of formula (I) or (I') can be dry milled and added to water containing the reagents described above to produce the desired end product.
氣霧劑配製物包含式(I)或(I’)的化合物和適宜的推進劑(例如,正丁烷)。也可將式(I)或(I’)的化合物溶於或分散於適宜的介質(例如水或可與水混溶的液體,如正丙醇)中以提供在不加壓的手動噴霧泵中使用的組合物。 The aerosol formulation comprises a compound of formula (I) or (I') and a suitable propellant (e.g., n-butane). The compound of formula (I) or (I') may also be dissolved or dispersed in a suitable medium such as water or a water-miscible liquid such as n-propanol to provide a manual spray pump which is not pressurized. The composition used in the process.
膠囊懸浮液(CS)可以藉由以與製備EW配製物類似的方式來製備,除了附加的聚合步驟之外,使得獲得油滴的水性分散體,其中每個油滴都被聚合物外殼包裹並且含有式(I)或(I’)的化合物以及,可任選地,為此的載體或稀釋劑。該聚合物外殼可以藉由界面縮聚反應或藉由凝聚程序來製備。該等組合物可以提供式(I)或(I’)的化合物的受控釋放並且它們可以用於種子處理。式(I)或(I’)的化合物也可以被配製在可生物降解的聚合物基質中,以提供該化合物的緩慢的受控釋放。 The capsule suspension (CS) can be prepared in a similar manner to the preparation of the EW formulation, except that in addition to the additional polymerization step, an aqueous dispersion of oil droplets is obtained, wherein each oil droplet is encapsulated by a polymer shell and Compounds containing formula (I) or (I') and, optionally, carriers or diluents for this purpose. The polymeric outer shell can be prepared by an interfacial polycondensation reaction or by a coacervation procedure. Such compositions can provide controlled release of the compounds of formula (I) or (I') and they can be used in seed treatment. Compounds of formula (I) or (I') may also be formulated in a biodegradable polymer matrix to provide a slow controlled release of the compound.
該組合物可以包括一或多種添加劑以改進該組合物的生物學性能(例如藉由改進表面上的濕潤性、保留或分佈;在處理過的表面上的抗雨性;式(I)或(I’)的化合物的吸收或遷移性)。這樣的添加劑包括表面活性劑(SFA)、基於油的噴霧添加劑,例如某些礦物油或天然植物油(例如大豆和油菜籽油),以及該等與其他生物增強佐劑(可幫助或改變式(I)或(I’)的化合物的作用的成分)的摻合物。 The composition may include one or more additives to improve the biological properties of the composition (e.g., by improving wettability, retention or distribution on the surface; rain resistance on the treated surface; formula (I) or ( Absorption or migration of the compound of I'). Such additives include surfactants (SFA), oil-based spray additives, such as certain mineral oils or natural vegetable oils (such as soybean and rapeseed oil), and these and other bio-enhancing adjuvants (which can help or change ( A blend of components of the action of I) or (I').
濕潤劑、分散劑和乳化劑可以是陽離子、陰離子、兩性的或非離子類型的SFA。 The humectants, dispersants and emulsifiers can be cationic, anionic, amphoteric or nonionic types of SFA.
適當的陽離子型的SFA包括季銨類化合物(例如十六烷基三甲基溴化 銨)、咪唑啉和胺鹽。 Suitable cationic SFAs include quaternary ammonium compounds such as cetyltrimethyl bromide Ammonium), imidazoline and amine salts.
適當的陰離子的SFA包括脂肪酸的鹼金屬鹽、硫酸脂肪族單酯的鹽(例如,月桂基硫酸鈉)、磺化的脂肪族化合物的鹽(例如,十二烷基苯磺酸鈉、十二烷基苯磺酸鈣、丁基萘磺酸鹽以及鈉的二異丙基和三異丙基萘的磺酸鹽混合物)、醚硫酸鹽、醇醚硫酸鹽(例如,月桂醇聚醚-3-硫酸鈉)、醚的羧酸鹽(例如月桂醇聚醚-3-羧酸鈉)、磷酸酯(一或多種脂肪醇與磷酸反應的產物(主要是單酯)或五氧化二磷之間的反應的產物(主要是二酯)、例如月桂基醇與四磷酸之間的反應;此外該等產物可以是乙氧基化的)、磺基琥珀醯胺酸鹽、石蠟或烯烴磺酸鹽、胺基乙磺酸鹽和木素磺酸鹽。 Suitable anionic SFAs include alkali metal salts of fatty acids, salts of fatty acid monoesters (eg, sodium lauryl sulfate), salts of sulfonated aliphatic compounds (eg, sodium dodecylbenzene sulfonate, twelve Calcium alkyl benzene sulfonate, butyl naphthalene sulfonate and sodium sulfonate mixture of diisopropyl and triisopropyl naphthalene), ether sulfate, alcohol ether sulfate (eg, laureth-3) - sodium sulfate), an ether carboxylate (such as sodium laureth-3-carboxylate), a phosphate ester (a product of one or more fatty alcohols reacted with phosphoric acid (mainly monoester) or phosphorus pentoxide The product of the reaction (mainly a diester), such as the reaction between lauryl alcohol and tetraphosphoric acid; in addition, the products may be ethoxylated), sulfosuccinamide, paraffin or olefin sulfonate , aminoethanesulfonate and lignosulfonate.
兩性類型的適當的SFA包括甜菜鹼、丙酸鹽和甘胺酸鹽。 Suitable SFAs of the amphoteric type include betaine, propionate and glycinate.
適當的非離子類型的SFA包括環氧烷(例如環氧乙烷、環氧丙烷、環氧丁烷或其混合物)與脂肪醇(例如油醇或鯨蠟醇)或與烷基酚(例如辛基酚、壬基酚或辛基甲酚)的縮合產物;衍生自長鏈脂肪酸或己糖醇酐的偏酯;所述偏酯與環氧乙烷的縮合產物;嵌段聚合物(含有環氧乙烷和環氧丙烷);烷醇醯胺;單酯(如脂肪酸聚乙二醇酯);胺氧化物(如月桂基二甲基氧化胺);以及卵磷脂。 Suitable nonionic types of SFA include alkylene oxides (such as ethylene oxide, propylene oxide, butylene oxide or mixtures thereof) with fatty alcohols (such as oleyl alcohol or cetyl alcohol) or with alkyl phenols (such as xin a condensation product of a phenol, a nonyl phenol or an octyl cresol; a partial ester derived from a long-chain fatty acid or a hexitol anhydride; a condensation product of the partial ester with ethylene oxide; a block polymer (containing a ring) Oxyethane and propylene oxide; alkanolamine; monoester (such as fatty acid polyethylene glycol ester); amine oxide (such as lauryl dimethyl amine oxide); and lecithin.
適當的懸浮劑包括親水膠體(如多糖類、聚乙烯吡咯啶酮或羧甲基纖維素鈉)和膨化粘土(如膨潤土或凹凸棒石)。 Suitable suspending agents include hydrophilic colloids (such as polysaccharides, polyvinylpyrrolidone or sodium carboxymethylcellulose) and expanded clays (such as bentonite or attapulgite).
本發明仍進一步提供了用於在場所調節植物生長的方法,其中,該方法包括向該場所施用植物生長調節量值的根據本發明的組合物。較佳的是,該組合物藉由噴霧施加而施用到植物的葉子上。 The invention still further provides a method for modulating plant growth at a locus, wherein the method comprises applying a plant growth regulating amount of the composition according to the invention to the locus. Preferably, the composition is applied to the foliage of the plant by spray application.
本發明還提供了用於促進種子萌發的方法,包括向該等種子、或者包 含種子的場所施用促進種子萌發量值的根據本發明的組合物。 The invention also provides methods for promoting seed germination, including to such seeds, or packages The seed-containing locus is applied to a composition according to the invention which promotes the amount of seed germination.
通常藉由噴灑該組合物進行施用,典型地是藉由用於大面積的裝在拖拉機上的噴霧機,但是還可以使用其他方法,例如撒粉(對於粉末)、滴加或浸濕。可替代地,該組合物可以在犁溝中施用或者在種植之前或種植時直接施用到種子上。 Application is usually carried out by spraying the composition, typically by means of a sprayer for large areas mounted on a tractor, but other methods such as dusting (for powder), dropping or wetting may also be used. Alternatively, the composition can be applied in the furrow or applied directly to the seed prior to planting or at the time of planting.
本發明的式(I)或(I’)的化合物或者組合物可以施用到植物、植物的部分、植物器官、植物繁殖材料上或其周圍區域中。 The compound or composition of the formula (I) or (I') of the present invention can be applied to a plant, a part of a plant, a plant organ, a plant propagation material or a surrounding area thereof.
在一實施方式中,本發明涉及處理植物繁殖材料的方法,包括將本發明的組合物以促進萌發和/或調節植物生長的有效量值施用到植物繁殖材料上。本發明還涉及用本發明的式(I)或(I’)的化合物或者組合物處理的植物繁殖材料。較佳的是,該植物繁殖材料係種子。 In one embodiment, the invention relates to a method of treating a plant propagation material comprising applying a composition of the invention to a plant propagation material in an amount effective to promote germination and/or modulate plant growth. The invention further relates to plant propagation material treated with a compound or composition of formula (I) or (I') of the invention. Preferably, the plant propagation material is a seed.
術語“植物繁殖材料”指的是所有的植物的生殖部分,例如種子,它可以被用於後者的繁殖以及植物性的植物材料,例如插條和塊莖。特別地,這裡可以提及種子、根、果實、塊莖、鱗莖以及根(狀)莖。 The term "plant propagation material" refers to the reproductive parts of all plants, such as seeds, which can be used for the propagation of the latter as well as vegetative plant materials such as cuttings and tubers. In particular, seeds, roots, fruits, tubers, bulbs and root stems can be mentioned here.
將活性成分施用到植物繁殖材料(尤其是種子)上的方法在本領域是已知的,並且包括繁殖材料的浸敷(dressing)、塗覆、造粒以及浸漬施用方法。該處理可以在種子收穫與種子播種之間的任何時間或在播種過程中施用到該種子上。該種子還可以在該處理之前或之後進行塗覆。該式(I)或(I’)的化合物可以任選地與控釋的塗覆或工藝組合施用,以便於該化合物隨時間而釋放。 Methods of applying active ingredients to plant propagation materials, particularly seeds, are known in the art and include dressing, coating, granulating, and dipping application methods of the propagation material. This treatment can be applied to the seed at any time between seed harvesting and seed sowing or during sowing. The seed can also be applied before or after the treatment. The compound of formula (I) or (I') can be optionally administered in combination with a controlled release coating or process to facilitate release of the compound over time.
本發明的組合物可以在出苗前或出苗後施用。適當的,當該組合物被用於調節作物植物生長時,可以在出苗前或出苗後施用,但是較佳的是在 作物的出苗後施用。當該組合物被用於促進種子萌發時,可以出苗前施用。 The composition of the present invention can be applied before or after emergence. Suitably, when the composition is used to adjust the growth of a crop plant, it may be applied before or after emergence, but preferably Post-emergence application of crops. When the composition is used to promote seed germination, it can be applied before emergence.
式(I)的化合物的施用率可以在廣泛範圍內變化並取決於土壤的性質、施用方法(出苗前或出苗後;種子浸敷;施用至種子犁溝;免耕應用等)、作物植物、主要氣候條件、以及由施用方法支配的其他因素、施用時間以及目標作物。用於葉或浸濕施用時,根據本發明的式I的化合物通常以從0.001到2000 g/ha,特別是從0.001到400 g/ha的比率施用。用於種子處理時,該施用率通常是在每100 kg種子0.0005與150 g之間。 The application rate of the compound of formula (I) can vary widely and depends on the nature of the soil, the method of application (pre-emergence or post-emergence; seed soaking; application to seed furrows; no-till applications, etc.), crop plants, The main climatic conditions, as well as other factors governed by the method of application, the time of application, and the target crop. For application to foliar or moist application, the compounds of formula I according to the invention are generally applied at a rate of from 0.001 to 2000 g/ha, in particular from 0.001 to 400 g/ha. For seed treatment, the application rate is usually between 0.0005 and 150 g per 100 kg of seed.
根據本發明的組合物可以用在其中的植物包括:作物如穀類(例如小麥、大麥、黑麥或燕麥);甜菜(例如甜菜或飼用甜菜);水果(例如梨果、核果或漿果,例如蘋果、梨、李子、桃、扁桃、櫻桃、草莓、覆盆子或黑莓);豆科植物(例如蠶豆、濱豆、豌豆或大豆);油料植物(例如油菜、芥菜、罌粟、橄欖、向日葵、椰子、蓖麻油植物、可哥豆或落花生);瓜類植物(例如嫩葫蘆、黃瓜或甜瓜);纖維植物(例如棉花、亞麻、大麻或黃麻);柑橘類水果(例如柳橙、檸檬、葡萄柚或橘子);蔬菜(例如菠菜、萵苣、蘆筍、捲心菜、胡蘿蔔、洋蔥、番茄、馬鈴薯、葫蘆或紅辣椒);樟科(例如鱷梨、樟(Cinnamon)或樟腦);玉米;水稻;菸草;堅果;咖啡;甘蔗;茶;葡萄藤;啤酒花;榴槤;香蕉;天然橡膠植物;草皮或觀賞植物(例如花卉、灌木、闊葉樹或常綠植物例如針葉樹)。該清單不代表任何限制。 Plants in which the composition according to the invention may be used include crops such as cereals (for example wheat, barley, rye or oats); beets (for example beets or beets); fruits (for example pears, stone fruits or berries, for example Apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries or blackberries); legumes (eg broad beans, lentils, peas or soybeans); oil plants (eg canola, mustard, poppy, olives, sunflowers, coconuts) , castor oil plant, cocoa or groundnut); melons (such as tender gourd, cucumber or melon); fiber plants (such as cotton, flax, hemp or jute); citrus fruits (such as orange, lemon, grapefruit) Or orange); vegetables (such as spinach, lettuce, asparagus, cabbage, carrots, onions, tomatoes, potatoes, gourds or red peppers); medlar (such as avocado, Cinnamon or camphor); corn; rice; tobacco; Nuts; coffee; sugar cane; tea; vines; hops; durian; bananas; natural rubber plants; turf or ornamental plants (eg flowers, shrubs, broadleaf or evergreens such as conifers) ). This list does not represent any restrictions.
本發明也可以用來調節生長,或促進非作物植物的種子萌發,例如,藉由同步萌發來幫助控制雜草。 The invention can also be used to regulate growth, or to promote seed germination of non-crop plants, for example, to help control weeds by simultaneous germination.
應當理解的作物還包括那些已經藉由常規的育種方法或藉由基因工程 改性的作物。例如,本發明可以與那些已經被賦予了對除草劑或多種類別的除草劑(例如ALS-、GS-、EPSPS-、PPO-、ACC酶、以及HPPD抑制劑)的耐受性的作物結合使用。藉由常規的育種方法已經賦予其對咪唑啉酮(例如,甲氧咪草煙)的耐受性的作物的例子係Clearfield®夏季油菜(卡羅拉)。由於遺傳工程方法而被賦予了對多種除草劑的耐受性的作物的實例包括草甘膦和草丁膦抗性玉米品種,該等玉米品種在RoundupReady®和LibertyLink®商標名下是可商購的。賦予作物植物對HPPD抑制劑的耐受性的方法係已知的,例如從WO0246387中;例如作物植物係關於多核苷酸轉基因的,該多核苷酸包括編碼衍生自細菌(更具體地說,來自螢光假單胞菌或希瓦氏菌(Shewanella colwelliana))或來自植物(更具體地說,衍生自單子葉植物或仍更具體地說,來自大麥、玉米、小麥、水稻、臂形草屬、Chenchrus、黑麥草屬、羊茅屬、狗尾草屬、蟋蟀草屬、高粱屬或燕麥屬物種)的HPPD抑制劑抗性的HPPD酶的DNA序列。 Crops that should be understood also include those that have been modified by conventional breeding methods or by genetic engineering. For example, the present invention can be used in combination with crops that have been rendered tolerant to herbicides or multiple classes of herbicides such as ALS-, GS-, EPSPS-, PPO-, ACC enzymes, and HPPD inhibitors. . An example of a crop that has been rendered tolerant to imidazolinones (e.g., imazamox) by conventional breeding methods is Clearfield® Summer Canola (Corolla). Examples of crops that have been rendered tolerant to a variety of herbicides due to genetic engineering methods include glyphosate and glufosinate resistant corn varieties, which are commercially available under the RoundupReady® and LibertyLink® brand names. of. Methods for conferring tolerance to crop plants to HPPD inhibitors are known, for example, from WO 0246387; for example, crop plant lines are transgenic with respect to polynucleotides, the polynucleotide comprising the coding derived from bacteria (more specifically, from Pseudomonas fluorescens or Shewanella colwelliana ) or from plants (more specifically, derived from monocots or still more specifically from barley, corn, wheat, rice, genus DNA sequence of HPPD inhibitor-resistant HPPD enzymes, Chenchrus , ryegrass, fescue, foxtail, valerian , sorghum or oats species.
作物還應理解為是已經藉由基因工程方法被賦予對有害昆蟲的抗性的那些,例如Bt玉米(抗歐洲玉米螟)Bt棉花(抗棉花棉鈴象甲)以及還有Bt馬鈴薯(抗科羅拉多甲蟲)。Bt玉米的實例係NK®的Bt 176玉米雜交體(先正達種子公司(Syngenta Seeds))。該Bt毒素係由蘇芸金芽胞桿菌土壤細菌自然形成的蛋白質。毒素或能合成此類毒素的轉基因植物的實例描述在例如EP-A-451 878、EP-A-374 753、WO 93/07278、WO 95/34656、WO 03/052073以及EP-A-427 529中。包含有一或多個編碼殺昆蟲劑抗性和表達一或多種毒素的基因的轉基因植物的例子係KnockOut®(玉米)、Yield Gard®(玉米)、NuCOTIN33B®(棉花)、Bollgard®(棉花)、NewLeaf®(馬鈴薯)、 NatureGard®和Protexcta®。其植物作物或種子均可以是抗除草劑的並且同時是抗昆蟲攝食(“疊加的”轉基因結果)。例如,種子材料可以具有表達殺昆蟲的Cry3蛋白能力同時是耐草甘膦的。 Crops are also understood to be those that have been rendered resistant to harmful insects by genetic engineering methods, such as Bt corn (anti-European corn borer) Bt cotton (anti-cotton boll weevil) and Bt potato (anti-Colorado beetle) ). An example of Bt corn is the NK® Bt 176 corn hybrid (Syngenta Seeds). The Bt toxin is a protein naturally formed by Bacillus thuringiensis soil bacteria. Examples of toxins or transgenic plants capable of synthesizing such toxins are described in, for example, EP-A-451 878, EP-A-374 753, WO 93/07278, WO 95/34656, WO 03/052073, and EP-A-427 529. in. Examples of transgenic plants comprising one or more genes encoding insecticide resistance and expression of one or more toxins are KnockOut® (corn), Yield Gard® (corn), NuCOTIN 33B® (cotton), Bollgard® (cotton), NewLeaf® (potato), NatureGard® and Protexcta®. Both plant crops or seeds can be herbicide resistant and at the same time resistant to insect feeding ("superimposed" transgenic results). For example, the seed material can have the ability to express insecticidal Cry3 protein while being glyphosate resistant.
作物還應理解為包括藉由常規的育種或基因工程的方法獲得並且包括所謂的輸出型(output)性狀(例如改進的存儲能力、更高的營養價值以及改進的香味)的那些。 Crops are also understood to include those obtained by conventional breeding or genetic engineering methods and including so-called output traits (e.g., improved storage capacity, higher nutritional value, and improved aroma).
本發明的化合物可以處於一種酯或酸的形式,其中任一者可以具有植物生長調節特性。如在WO2009/109570中提出的,式(I)的化合物的酯的形式被認為是可以在植物中水解為酸的形式的。當該酯化的化合物更容易被植物(例如藉由葉片組織)吸收時,這可以是特別的優點。 The compounds of the invention may be in the form of an ester or acid, any of which may have plant growth regulating properties. As suggested in WO 2009/109570, the ester form of the compound of formula (I) is considered to be hydrolyzable to the acid form in plants. This can be a particular advantage when the esterified compound is more readily absorbed by plants (e.g., by leaf tissue).
在本發明的另一方面中,本發明的化合物或組合物可以與一或多種具有殺有害生物作用的化合物組合施用。該等化合物包括那些具有殺真菌的、除草的、安全的、植物生長調節的、殺昆蟲的、殺線蟲的或殺蟎的活性的化合物。 In another aspect of the invention, the compounds or compositions of the invention may be administered in combination with one or more compounds having a pesticidal action. Such compounds include those having fungicidal, herbicidal, safe, plant growth regulating, insecticidal, nematicidal or acaricidal activity.
在本發明的另一方面中,本發明的化合物或組合物可以與一或多種其他的具有作物增強作用的化合物組合施用。該等化合物包括微量營養素、醣類、胺基酸、類黃酮、奎寧、以及植物活化劑/生長刺激劑。例如,該等化合物包括天然的或合成的激素、茁長素、油菜素內酯(brassinosteroid)、赤黴素、脫落酸、細胞激素、茉莉酸、金內酯(strigolactones)、水楊酸、乙烯、1-甲基環丙烯、抗倒酯乙酯或其衍生物。該等化合物還包括具有作物增強作用的殺有害生物劑,例如,丙烯酸酯類(strobilurin,包括嘧菌酯、唑菌胺酯),以及新煙鹼類(包括噻蟲嗪、以及吡蟲啉)。 In another aspect of the invention, the compounds or compositions of the invention may be administered in combination with one or more other compounds having crop enhancing effects. Such compounds include micronutrients, sugars, amino acids, flavonoids, quinine, and plant activators/growth stimulators. For example, such compounds include natural or synthetic hormones, auxin, brassinosteroid, gibberellin, abscisic acid, cytokines, jasmonic acid, strigolactones, salicylic acid, ethylene , 1-methylcyclopropene, trinexaethyl ester or a derivative thereof. Such compounds also include pesticidal agents having crop enhancing effects, for example, strobilurins (including azoxystrobin, pyraclostrobin), and neonicotinoids (including thiamethoxam, and imidacloprid).
本發明的該等化合物可以藉由下面的方法來製備。 The compounds of the present invention can be prepared by the following methods.
式(I)或(I’)的化合物可以從式(III)的化合物經由醯化藉由式(II)的化合物反應而製備,其中,Z係鹵素如氯並且R8係C1-C6烷基、C1-C6鹵烷基、由羥基或胺取代的C1-C6烷基(受保護的或未受保護的),此類反應通常在鹼存在下並且較佳的是在親核催化劑存在下進行。作為替代方案,有可能在包括有機溶劑(較佳的是乙酸乙酯)、及水性溶劑(較佳的是碳酸氫鈉溶液)的雙相系統中進行此反應。 The compound of the formula (I) or (I') can be produced by reacting a compound of the formula (III) with a compound of the formula (II) via deuteration, wherein a Z-based halogen such as chlorine and an R8-based C1-C6 alkyl group, C1-C6 haloalkyl, C1-C6 alkyl (protected or unprotected) substituted by hydroxy or amine, such reaction is usually carried out in the presence of a base and preferably in the presence of a nucleophilic catalyst. Alternatively, it is possible to carry out the reaction in a two-phase system comprising an organic solvent, preferably ethyl acetate, and an aqueous solvent, preferably sodium bicarbonate solution.
式(II)的化合物係可商購的,例如甲基琥珀酸酯氯化物(methyl succinate chloride)或者可以藉由熟習該項技術者已知的方法製備。 The compound of formula (II) is commercially available, for example, methyl succinate chloride or can be prepared by methods known to those skilled in the art.
流程2Process 2
式(Ia)的化合物可以在例如乙醇或四氫呋喃的溶劑中,在水存在的條件下,藉由例如用鹼金屬氫氧化物如氫氧化鈉或氫氧化鉀處理式(I)或(I’)的化合物(其中,R8係C1-C6烷基、C1-C6鹵烷基、由羥基或胺取代的C1-C6烷基(受保護的或未受保護的))藉由在標準條件下水解來製備。另一替代方案係用酸(如三氟乙酸),在溶劑(如二氯甲烷)中處理式(Ia)的酯,隨後添加水。該反應較佳係在從-20℃至+100℃的溫度、更佳的是從20℃至80℃,特別是在50℃下進行的。 The compound of the formula (Ia) can be treated in a solvent such as ethanol or tetrahydrofuran in the presence of water, for example, by treating the formula (I) or (I') with an alkali metal hydroxide such as sodium hydroxide or potassium hydroxide. a compound (wherein R 8 is a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 alkyl group (protected or unprotected) substituted by a hydroxyl group or an amine) is hydrolyzed under standard conditions. To prepare. Another alternative is to treat the ester of formula (Ia) with an acid such as trifluoroacetic acid in a solvent such as dichloromethane followed by the addition of water. The reaction is preferably carried out at a temperature of from -20 ° C to +100 ° C, more preferably from 20 ° C to 80 ° C, especially at 50 ° C.
流程3Process 3
式(I)或(I’)的化合物可以從式(Ia)的化合物經由醯化反應藉由在偶合劑,例如,DCC(N,N'-二環己基-碳二亞胺)、EDC(1-乙基-3-[3-二甲胺基-丙基]碳二亞胺鹽酸鹽)或者BOP-Cl(二(2-側氧-3-唑啶基)氯化膦)存在下,在鹼(例如吡啶、三乙胺、4-(二甲胺基)吡啶或者二異丙基乙胺)存在下,並且任選地在親核催化劑如羥基苯并三唑存在下藉由醇衍生物反應來製備。 The compound of formula (I) or (I') can be passed from a compound of formula (Ia) via a deuteration reaction by a coupling agent, for example, DCC ( N,N' -dicyclohexyl-carbodiimide), EDC ( 1-ethyl-3-[3-dimethylamino-propyl]carbodiimide hydrochloride) or BOP-Cl (bis(2-oxo-3-) In the presence of an oxazolidinylphosphine), in the presence of a base such as pyridine, triethylamine, 4-(dimethylamino)pyridine or diisopropylethylamine, and optionally in a nucleophilic catalyst such as It is prepared by reacting an alcohol derivative in the presence of hydroxybenzotriazole.
作為替代方案,式(I)或(I’)的化合物可以從式(Ib)的化合物經由醯化反應製備。醯化反應可以在鹼性條件下(例如在吡啶、三乙胺、4-(二甲胺基)吡啶或者二異丙基乙胺存在下)在適當的溶劑(如四氫呋喃)中,可任選的在親核催化劑存在下進行。該反應係在從-120℃至+130℃,較佳的是從-100℃至100℃的溫度下進行的。作為替代方案,該反應可以在兩相系統(包括有機溶劑,較佳的是乙酸乙酯,以及水性溶劑,較佳的是碳酸氫鈉 的飽和溶液)中進行。 Alternatively, a compound of formula (I) or (I') can be prepared from a compound of formula (Ib) via a oximation reaction. The deuteration reaction can be carried out under basic conditions (for example, in the presence of pyridine, triethylamine, 4-(dimethylamino)pyridine or diisopropylethylamine) in a suitable solvent such as tetrahydrofuran. It is carried out in the presence of a nucleophilic catalyst. The reaction is carried out at a temperature of from -120 ° C to +130 ° C, preferably from -100 ° C to 100 ° C. Alternatively, the reaction can be carried out in a two-phase system (including an organic solvent, preferably ethyl acetate, and an aqueous solvent, preferably sodium bicarbonate In a saturated solution).
式(Ib)的化合物可以從式(Ia)的化合物在溶劑(如二氯甲烷)中,在標準條件下例如用亞硫醯二氯或者草醯氯處理來製備。該反應較佳的是在從-20℃至+100℃的溫度、更佳的是從0℃至50℃,特別是在環境溫度下進行的。 Compounds of formula (Ib) can be prepared from compounds of formula (Ia) in a solvent such as dichloromethane under standard conditions, for example with sulfoxide dichloride or chloroform. The reaction is preferably carried out at a temperature of from -20 ° C to +100 ° C, more preferably from 0 ° C to 50 ° C, especially at ambient temperature.
式(Ia)的化合物可以藉由處理式(III)的化合物藉由在溶劑(例如四氫呋喃)中用式(IV)的酸酐衍生物,如琥珀醯酸酐處理來製備。該反應較佳的是在從-20℃至+120℃、更佳的是從20℃至120℃的溫度下進行的。 Compounds of formula (Ia) can be prepared by treating a compound of formula (III) by treatment with an anhydride derivative of formula (IV), such as succinic anhydride, in a solvent such as tetrahydrofuran. The reaction is preferably carried out at a temperature of from -20 ° C to +120 ° C, more preferably from 20 ° C to 120 ° C.
式(I)或(I’)的化合物(其中,X係芳基,雜芳基或C3-C8環烷基衍生物,如噻吩、乙烯基、烯丙基或環丙基)可以藉由在適當的催化劑/配位基系統(通常是鈀(0)鍺合物)存在下並且在鹼(例如,碳酸鉀)存在或不存在下,使式(Ic)的化合物(其中,LG係適當的離去基團,如,例如鹵素或三氟甲磺酸鹽)與式Z-X的衍生物(其中,Z係硼或錫衍生物並且X係如對於式(I)或(I’)的化合物所說明的)的反應來製備。該等反應可以或可以不在微波輻射下進行。該等反應係為熟習該項技術者所知的在史帝勒(Stille)、蘇楚基(Suzuki)偶合的名下的,參見例如:有機合成中命名反應的戰略性應用(Strategic Applications of Named Reactions in Organic Synthesis);庫爾蒂.拉茲羅(Kurti,Laszlo);曹科.芭芭拉(Czako,Barbara);編者.USA.(2005),出版社:愛思唯爾學術出版社,伯靈頓,麻塞諸塞州.p.448(蘇楚基偶合)以及p.438(史帝勒偶合)以及引用的參考文獻。 a compound of the formula (I) or (I') wherein the X-based aryl, heteroaryl or C 3 -C 8 cycloalkyl derivative such as thiophene, vinyl, allyl or cyclopropyl may be borrowed Compounds of formula (Ic) wherein LG is present in the presence of a suitable catalyst/coordination system (typically a palladium (0) conjugate) and in the presence or absence of a base (eg, potassium carbonate) a suitable leaving group such as, for example, a halogen or a triflate salt, and a derivative of the formula ZX (wherein a Z-based boron or tin derivative and X is as defined for formula (I) or (I') The reaction described by the compound) is prepared. These reactions may or may not be carried out under microwave irradiation. Such reactions are known to those skilled in the art under the names of Stille and Suzuki coupling, see, for example, the strategic application of named reactions in organic synthesis (Strategic Applications of Named Reactions in Organic Synthesis); Kurti. Kurti (Laszlo); Cao Ke. Barbara (Czako, Barbara); Editor. USA. (2005), Publisher: Elsevier Academic Press, Burlington, Massachusetts. p.448 (Succhi coupling) and p.438 ( Stiller coupling) and cited references.
式(I)或(I’)的化合物(其中,X係CCR,其中,R係C1-C6烷基、氫或者三烷基矽基)可以藉由在適當的催化劑/配位基系統(通常是具有或不具有如碘化亞銅的銅源的鈀(0)鍺合物)存在下在並且在有機鹼(例如,二 異丙基乙胺)存在或不存在下,使式(Ic)的化合物(其中,LG係適當的離去基團,如,例如鹵素或三氟甲磺酸鹽)與式HCCR的衍生物的反應來製備。該反應係為熟習該項技術者所知的在薗頭偶合反應(Sonogashira coupling)名下的,見例如:有機合成中命名反應的戰略性應用;庫爾蒂.拉茲羅(Kurti,Laszlo);曹科.芭芭拉(Czako,Barbara);編者.USA.(2005),出版社:愛思唯爾學術出版社,伯靈頓,麻塞諸塞州.p.424(薗頭偶合)以及引用的參考文獻。 Compounds of formula (I) or (I') wherein X-CCR, wherein R-C 1 -C 6 alkyl, hydrogen or trialkylsulfonyl, may be employed in a suitable catalyst/coordination system (usually a palladium (0) conjugate with or without a copper source such as cuprous iodide) in the presence and absence of an organic base (eg, diisopropylethylamine), The compound of Ic), wherein LG is a suitable leaving group such as, for example, a halogen or a triflate, is prepared by reacting a derivative of the formula HCCR. The reaction is known to those skilled in the art under the name Sonogashira coupling, see, for example, the strategic application of named reactions in organic synthesis; Curti. Kurti (Laszlo); Cao Ke. Barbara (Czako, Barbara); Editor. USA. (2005), Publisher: Elsevier Academic Press, Burlington, Massachusetts. p. 424 (cococouple) and citations literature.
式(I)或(I’)的化合物(其中,X係CCH)可以藉由式(I)或(I’)的化合物(其中,X係CCSiR3,其中,R係C1-C6烷基)的反應藉由與鹼,(例如,碳酸鉀)或氟化物源(例如氟化鉀)進行反應來製備。 The compound of the formula (I) or (I') (wherein the X-based CCH) may be a compound of the formula (I) or (I') (wherein the X-based CCSiR 3 wherein the R-based C1-C6 alkyl group) The reaction is prepared by reaction with a base, such as potassium carbonate or a fluoride source such as potassium fluoride.
式(I)或(I’)的化合物(其中,W係硫)可以從式(I)或(I’)的化合物(其中,W係氧)藉由用硫代轉移試劑(例如,勞維森試劑(Lawesson’s reagent)或五硫化二磷)的處理來製備。 A compound of formula (I) or (I') wherein W is sulfur may be derived from a compound of formula (I) or (I') (wherein W is oxygen) by a thiotransfer reagent (eg, lovi) Prepared by treatment with Lawesson's reagent or phosphorus pentasulfide.
以下的HPLC-MS的方法用於分析該等化合物: The following HPLC-MS method was used to analyze the compounds:
在來自沃特斯(Waters)的ZQ質譜儀(單相四極質譜儀)上記錄光譜,該質譜儀配備有電灑源(極性:正離子或負離子,毛細管:3.00 kV,錐孔:30.00 V,萃取器:2.00 V,源溫度:100℃,去溶溫度:250℃,錐孔氣體流量:50 L/Hr,去溶氣體流量:400 L/Hr;質量範圍:100 Da至900 Da)以及安捷倫(Agilent)1100 LC(溶劑脫氣器、二元泵、加熱管柱室以及二極體陣列檢測器)。柱:Phenomenex Gemini C18,3μm,30×3 mm,溫度:60℃; DAD波長範圍(nm):210到500,溶劑梯度:A=水+0.05%甲酸,B=乙腈/甲醇(4:1,v:v)+0.04%甲酸;梯度:0 min 5% B;2-2.8 min 100% B;2.9-3 min 5%。流量(ml/min)1.7 The spectra were recorded on a ZQ mass spectrometer (single-phase quadrupole mass spectrometer) from Waters equipped with an electrospray source (polarity: positive or negative, capillary: 3.00 kV, taper: 30.00 V, Extractor: 2.00 V, source temperature: 100 ° C, desolvation temperature: 250 ° C, cone gas flow: 50 L/Hr, desolvated gas flow: 400 L/Hr; mass range: 100 Da to 900 Da) and Agilent (Agilent) 1100 LC (solvent degasser, binary pump, heated column chamber, and diode array detector). Column: Phenomenex Gemini C18, 3 μm, 30 × 3 mm, temperature: 60 ° C; DAD wavelength range (nm): 210 to 500, solvent gradient: A = water + 0.05% formic acid, B = acetonitrile / methanol (4: 1, v: v) + 0.04% formic acid; gradient: 0 min 5% B; -2.8 min 100% B; 2.9-3 min 5%. Flow rate (ml/min) 1.7
在來自沃特斯(Waters)的ZQ質譜儀(單相四極質譜儀)上記錄光譜,該質譜儀配備有電灑源(極性:正離子或負離子,毛細管:3.00 kV,錐孔:30.00 V,萃取器:2.00 V,源溫度:100℃,去溶溫度:250℃,錐孔氣體流量:50 L/Hr,去溶氣體流量:400 L/Hr;質量範圍:100 Da至900 Da)以及安捷倫(Agilent)1100 LC(溶劑脫氣器、二元泵、加熱管柱室以及二極體陣列檢測器)。柱:Phenomenex Gemini C18,3μm,30×3 mm,溫度:60℃;DAD波長範圍(nm):210到500,溶劑梯度:A=水+5%甲醇+0.05%甲酸,B=乙腈+0.05%甲酸;梯度:0 min 0% B;2-2.8 min 100% B;2.9-3 min 0%。流量(ml/min)1.7 The spectra were recorded on a ZQ mass spectrometer (single-phase quadrupole mass spectrometer) from Waters equipped with an electrospray source (polarity: positive or negative, capillary: 3.00 kV, taper: 30.00 V, Extractor: 2.00 V, source temperature: 100 ° C, desolvation temperature: 250 ° C, cone gas flow: 50 L/Hr, desolvated gas flow: 400 L/Hr; mass range: 100 Da to 900 Da) and Agilent (Agilent) 1100 LC (solvent degasser, binary pump, heated column chamber, and diode array detector). Column: Phenomenex Gemini C18, 3 μm, 30 × 3 mm, temperature: 60 ° C; DAD wavelength range (nm): 210 to 500, solvent gradient: A = water + 5% methanol + 0.05% formic acid, B = acetonitrile + 0.05% Formic acid; Gradient: 0 min 0% B; 2-2.8 min 100% B; 2.9-3 min 0%. Flow rate (ml/min) 1.7
在來自沃特斯(Waters)的ZQ質譜儀(單相四極質譜儀)上記錄光譜,該質譜儀配備有電灑源(極性:正離子或負離子,毛細管:3.00 kV,錐孔範圍:30 V至60 V,萃取器:2.00 V,源溫度:150℃,去溶溫度:350℃,錐孔氣體流量:50 L/Hr,去溶氣體流量:40 0L/Hr;質量範圍:100 Da至900 Da)以及來自沃特斯(Waters)的Acquity UPLC:二元泵、加熱管柱室以及二極體陣列檢測器。溶劑脫氣器,二元泵,加熱管柱室以及二極體陣列檢測器。柱:Waters UPLC HSS T3,1.8μm,30×2.1 mm,溫度:60℃;DAD波長範圍(nm):210到500,溶劑梯度:A=水+5%甲醇+0.05%甲酸,B= 乙腈+0.05%甲酸;梯度:0 min 10% B,90%A;1.2-1.5 min 100% B;流量(ml/min)0.85 Spectra were recorded on a ZQ mass spectrometer (single-phase quadrupole mass spectrometer) from Waters equipped with an electric sprinkler (polarity: positive or negative, capillary: 3.00 kV, cone range: 30 V) Up to 60 V, extractor: 2.00 V, source temperature: 150 ° C, desolvation temperature: 350 ° C, cone gas flow: 50 L/Hr, desolvated gas flow: 40 0 L/Hr; mass range: 100 Da to 900 Da) and Acquity UPLC from Waters: Binary Pump, Heating Column Chamber, and Diode Array Detector. Solvent degasser, binary pump, heated column chamber and diode array detector. Column: Waters UPLC HSS T3, 1.8 μm, 30 × 2.1 mm, temperature: 60 ° C; DAD wavelength range (nm): 210 to 500, solvent gradient: A = water + 5% methanol + 0.05% formic acid, B = Acetonitrile + 0.05% formic acid; Gradient: 0 min 10% B, 90% A; 1.2-1.5 min 100% B; flow rate (ml/min) 0.85
在來自沃特斯(Waters)的SQD質譜儀(單相四極質譜儀)上記錄光譜,該質譜儀配備有電灑源(極性:正離子或負離子,毛細管:3.00 kV,錐孔範圍:30 V至60 V,萃取器:2.00 V,源溫度:150℃,去溶溫度:250℃,錐孔氣體流量:0 L/Hr,去溶氣體流量:650 L/Hr;質量範圍:100 Da至900 Da)以及來自沃特斯(Waters)的Acquity UPLC:二元泵、加熱管柱室以及二極體陣列檢測器。溶劑脫氣器,二元泵,加熱管柱室以及二極體陣列檢測器。柱:Phenomenex Gemini C18,3μm,30×2 mm,溫度:60℃;DAD波長範圍(nm):210到500,溶劑梯度:A=水+5%甲醇+0.05%甲酸,B=乙腈+0.05%甲酸;梯度:梯度:0 min 0% B,100%A;1.2-1.5 min 100% B;流量(ml/min)0.85 Spectra were recorded on an SQD mass spectrometer (single-phase quadrupole mass spectrometer) from Waters equipped with an electric sprinkler (polarity: positive or negative, capillary: 3.00 kV, cone range: 30 V) Up to 60 V, extractor: 2.00 V, source temperature: 150 ° C, desolvation temperature: 250 ° C, cone gas flow: 0 L/Hr, desolvated gas flow: 650 L/Hr; mass range: 100 Da to 900 Da) and Acquity UPLC from Waters: Binary Pump, Heating Column Chamber, and Diode Array Detector. Solvent degasser, binary pump, heated column chamber and diode array detector. Column: Phenomenex Gemini C18, 3 μm, 30 × 2 mm, temperature: 60 ° C; DAD wavelength range (nm): 210 to 500, solvent gradient: A = water + 5% methanol + 0.05% formic acid, B = acetonitrile + 0.05% Formic acid; Gradient: Gradient: 0 min 0% B, 100% A; 1.2-1.5 min 100% B; flow rate (ml/min) 0.85
用於方法C的同樣的條件,除了光譜儀是:來自沃特斯(Waters)的SDQ質譜儀(單相四極質譜儀) The same conditions used for Method C except that the spectrometer is: SDQ mass spectrometer (single phase quadrupole mass spectrometer) from Waters
在來自沃特斯(Waters)的(SDQ或ZQ單相四極質譜儀)質譜儀上記錄光譜,該質譜儀配備有電灑源(極性:正離子或負離子,毛細管:3.00 kV,錐孔:30-60 V,萃取器:2.00 V,源溫度:150℃,去溶溫度:350℃,錐孔氣體流量:0 L/Hr,去溶氣體流量:650 L/Hr;質量範圍:100 Da至900 Da)以及來自沃特斯(Waters)的Acquity UPLC:二元泵、加熱管柱室以及二極 體陣列檢測器)。溶劑脫氣器,二元泵,加熱管柱室以及二極體陣列檢測器。柱:Waters UPLC HSS T3,1.8μm,30×2.1 mm,溫度:60℃;DAD波長範圍(nm):210到500,溶劑梯度:A=水+5%甲醇+0.05%甲酸,B=乙腈+0.05%甲酸;梯度:梯度:0 min 0% B,100%A;1.2-1.5 min 100% B;流量(ml/min)0.85 Spectra were recorded on a Waters (SDQ or ZQ single-phase quadrupole mass spectrometer) mass spectrometer equipped with an electrospray source (polarity: positive or negative, capillary: 3.00 kV, cone: 30 -60 V, extractor: 2.00 V, source temperature: 150 ° C, desolvation temperature: 350 ° C, cone gas flow: 0 L/Hr, desolvated gas flow: 650 L/Hr; mass range: 100 Da to 900 Da) and Acquity UPLC from Waters: Binary pump, heated column chamber and two poles Body array detector). Solvent degasser, binary pump, heated column chamber and diode array detector. Column: Waters UPLC HSS T3, 1.8 μm, 30 × 2.1 mm, temperature: 60 ° C; DAD wavelength range (nm): 210 to 500, solvent gradient: A = water + 5% methanol + 0.05% formic acid, B = acetonitrile + 0.05% formic acid; Gradient: Gradient: 0 min 0% B, 100% A; 1.2-1.5 min 100% B; flow rate (ml/min) 0.85
整個本部分使用了以下縮寫:s=單峰;bs=寬峰;d=二重峰;dd=雙二重峰;dt=雙三重峰;t=三重峰;tt=三三重峰;q=四重峰;m=多重峰;Me=甲基;Et=乙基;Pr=丙基;Bu=丁基;M.p.=熔點;RT=滯留時間;[M+H]+=分子陽離子(例如,測量的分子量)。 The following abbreviations are used throughout this section: s = single peak; bs = broad peak; d = doublet; dd = doublet; dt = double triplet; t = triplet; tt = triplet; = quartet; m = multiplet; Me = methyl; Et = ethyl; Pr = propyl; Bu = butyl; Mp = melting point; RT = residence time; [M + H] + = molecular cation (eg , measured molecular weight).
中間產物的合成: Synthesis of intermediates:
在氮氣氛下,向5-溴-3-甲氧基-吡啶-2-胺(3.00 g,14.8 mmol)在N,N-二甲基甲醯胺(55 mL)中的溶液內加入氰化鋅(II)(2.78 g,23.6 mmol)以及四(三苯基膦)鈀(0)(2.06 g,1.77 mmol)。將反應混合物在100℃下攪拌4 h。將該反應混合物用乙酸乙酯稀釋,並且相繼地用氫氧化銨的飽和溶液以及鹽水洗滌。分離各相。有機相用硫酸鈉乾燥並且濃縮。殘餘物藉由矽膠柱層析法純化(洗提劑:乙酸乙酯/環己烷1:5),得到6-胺基-5-甲氧基-吡啶-3-腈(1.2 g,54%產率)。1H NMR(400 MHz,CDCl3):7.99(s,1H),6.99(s,1H),3.88(s,3H)ppm。13C NMR(100 MHz,CDCl3):152.83,144.58,141.27,118.32, 115.52,97.66,55.65。LC-MS(方法B):RT 0.69,150(M+H+) Add cyanide to a solution of 5-bromo-3-methoxy-pyridin-2-amine (3.00 g, 14.8 mmol) in N,N -dimethylformamide (55 mL) under nitrogen. Zinc (II) (2.78 g, 23.6 mmol) and tetrakis(triphenylphosphine)palladium (0) (2.06 g, 1.77 mmol). The reaction mixture was stirred at 100 ° C for 4 h. The reaction mixture was diluted with ethyl acetate and washed successively with aq. Separate the phases. The organic phase was dried over sodium sulfate and concentrated. The residue was purified by silica gel column chromatography (eluent: ethyl acetate / cyclohexane: 1:5) to give 6-amino-5-methoxy-pyridine-3-carbonitrile (1.2 g, 54%) Yield). 1 H NMR (400 MHz, CDCl 3 ): 7.99 (s, 1H), 6.99 (s, 1H), 3.88 (s, 3H) ppm. 13 C NMR (100 MHz, CDCl 3 ): 152.83, 144.58, 141.27, 118.32, 115.52, 97.66, 55.65. LC-MS (Method B): RT 0.69, 150 (M+H + )
下面的化合物藉由同樣的方法用商業的或者所說明的起始胺基吡啶製備:6-胺基-5-(三氟甲基)吡啶-3-腈(也可商購的):用於A42的起始材料 The following compounds were prepared by the same procedure using the commercial or illustrated starting aminopyridine: 6-amino-5-(trifluoromethyl)pyridine-3-carbonitrile (also commercially available): Starting material for A42
將6-胺基-3-氰基吡啶(可商購的,0.470 g,1.0當量)溶解於四氫呋喃(10 mL)中,然後相繼加入N,N-二甲基苯胺(0.5 mL,1.0當量)以及-4-氯-4-側氧-丁酸甲酯(0.54 mL,1.1當量)。將該混合物回流12 h。停止該反應,並且將該溶液在乙酸乙酯與水之間分配。分離出水層並且用乙酸乙酯(2x)萃取。將合併的有機層在硫酸鎂上乾燥該並在真空中濃縮。藉由快速層析法用環己烷-乙酸乙酯洗提來純化該殘餘物,從而得到4-[(5-氰基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A1(71%)。M.p.=161℃-164℃。1H NMR(400 MHz,DMSO-d6)δ 8.78(s,1H),8.20(m,2H),3.58(s,3H),2.74(t,2H),2.61(t,2H)ppm。LC-MS(方法B):RT 1.19,234(M+H+) 6-Amino-3-cyanopyridine (commercially available, 0.470 g, 1.0 eq.) was dissolved in tetrahydrofuran (10 mL), then N,N -dimethylaniline (0.5 mL, 1.0 eq. And methyl 4-chloro-4-oxo-butyrate (0.54 mL, 1.1 eq.). The mixture was refluxed for 12 h. The reaction was stopped and the solution was partitioned between ethyl acetate and water. The aqueous layer was separated and extracted with ethyl acetate (2×). The combined organic layers were dried over MgSO4 and concentrated in vacuo. The residue was purified by flash chromatography eluting with cyclohexane-ethyl acetate to give 4-[(5-cyano-2-pyridyl)amino]-4-oxo-butyric acid Ester A1 (71%). Mp = 161 ° C - 164 ° C. 1 H NMR (400 MHz, DMSO-d6) δ 8.78 (s, 1H), 8.20 (m, 2H), 3.58 (s, 3H), 2.74 (t, 2H), 2.61 (t, 2H) ppm. LC-MS (Method B): RT 1.19,234 (M+H + )
下面的來自表A或者B的化合物藉由同樣的方法用商業的或者所說明的起始胺基吡啶製備:4-[(3-氰基-5-碘-2-吡啶基)胺基]-4-側氧-丁酸甲酯A3 The following compounds from Table A or B were prepared by the same procedure using the commercial or illustrated starting aminopyridine: 4-[(3-cyano-5-iodo-2-pyridyl)amino]- 4-sided oxygen-butyric acid methyl ester A3
4-[(3-溴-5-氯-2-吡啶基)胺基]-4-側氧-丁酸甲酯A5 4-[(3-Bromo-5-chloro-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A5
4-[(5-溴-3-甲氧基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A6 4-[(5-bromo-3-methoxy-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A6
4-[(5-氰基-3-甲氧基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A7 4-[(5-Cyano-3-methoxy-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A7
4-[(5-溴-3-氯-2-吡啶基)胺基]-4-側氧-丁酸甲酯A8 4-[(5-bromo-3-chloro-2-pyridinyl)amino]-4-oxo-butyric acid methyl ester A8
4-[(5-氰基-4,6-二甲基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A9 4-[(5-Cyano-4,6-dimethyl-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A9
4-[(3-氯-5-氰基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A10 4-[(3-chloro-5-cyano-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A10
4-[(3,5-二氯-2-吡啶基)胺基]-4-側氧-丁酸甲酯A11 4-[(3,5-Dichloro-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A11
4-側氧-4-[(3,5,6-三氯-2-吡啶基)胺基]丁酸甲酯A12 4-oxo-4-[(3,5,6-trichloro-2-pyridyl)amino]butyric acid methyl ester A12
4-[(5-氰基-2-吡啶基)胺基]-4-側氧-丁酸乙基酯A22,藉由同樣的方用4-氯-4-側氧-丁酸乙基酯替換甲基-4-氯-4-側氧-丁酸酯合成 4-[(5-Cyano-2-pyridyl)amino]-4-oxo-butyric acid ethyl ester A22 , 4-chloro-4-oxo-butyric acid ethyl ester by the same method Replacement of methyl-4-chloro-4-oxo-butyrate synthesis
4-側氧-4-[[5-[1,2,2,2-四氟-1-(三氟甲基)乙基]-2-吡啶基]胺基]丁酸甲酯A24 4-sided oxo-4-[[5-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-2-pyridyl]amino]butyric acid methyl ester A24
4-[(5-溴-6-甲氧基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A26 4-[(5-Bromo-6-methoxy-2-pyridinyl)amino]-4-oxo-butyric acid methyl ester A26
4-[(5-甲基硫烷基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A29 4-[(5-Methylsulfanyl-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A29
4-[(5-甲氧基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A30 4-[(5-methoxy-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A30
4-[(5-氯-4-乙氧基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A31 4-[(5-chloro-4-ethoxy-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A31
4-[(5-乙醯基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A33 4-[(5-Ethyl-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A33
4-[(5-氰基-6-甲基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A35 4-[(5-Cyano-6-methyl-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A35
4-[(5-氰基-2-吡啶基)胺基]-2,2-二甲基-4-側氧-丁酸甲酯B1,在使用草醯氯以及一滴DMF產生酸氯化物的類似物之後,作為反應劑使用商用2,2'-二甲基琥珀酸甲基酯 4-[(5-Cyano-2-pyridyl)amino]-2,2-dimethyl-4-oxo-butyric acid methyl ester B1, using acid chloride and a drop of DMF to produce acid chloride After the analog, commercial 2,2'-dimethylsuccinate methyl ester was used as a reactant
6-[(4-甲氧基-4-側氧-丁醯基)胺基]吡啶-3-羧酸甲基酯A37 6-[(4-Methoxy-4-oxo-butenyl)amino]pyridine-3-carboxylic acid methyl ester A37
4-[(5-溴-4-乙氧基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A38 4-[(5-Bromo-4-ethoxy-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A38
4-[[5-氰基-3-(三氟甲基)-2-吡啶基]胺基]-4-側氧-丁酸甲酯A42 4-[[5-Cyano-3-(trifluoromethyl)-2-pyridinyl]amino]-4-oxo-butyric acid methyl ester A42
4-[[5-溴-3-(三氟甲基)-2-吡啶基]胺基]-4-側氧-丁酸甲酯A44 4-[[5-bromo-3-(trifluoromethyl)-2-pyridinyl]amino]-4-oxo-butyric acid methyl ester A44
4-[[3-氯-5-(三氟甲基)-2-吡啶基]胺基]-4-側氧-丁酸甲酯A46 4-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]amino]-4-oxo-butyric acid methyl ester A46
4-[(5-氰基-3-甲基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A48 4-[(5-Cyano-3-methyl-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A48
4-[(5-溴-6-氯-2-吡啶基)胺基]-4-側氧-丁酸甲酯A49 4-[(5-Bromo-6-chloro-2-pyridinyl)amino]-4-oxo-butyric acid methyl ester A49
4-[(5-硝基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A55 4-[(5-nitro-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A55
4-[(5-甲磺醯基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A56 4-[(5-Methanesulfonyl-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A56
4-[(5-氯-4-甲氧基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A57 4-[(5-chloro-4-methoxy-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A57
4-[(5-氯-6-甲氧基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A58 4-[(5-chloro-6-methoxy-2-pyridinyl)amino]-4-oxo-butyric acid methyl ester A58
4-[(5-溴-4-甲氧基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A59 4-[(5-Bromo-4-methoxy-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A59
4-側氧-4-[[5-(1,1,2,2,2-五氟乙基)-2-吡啶基]胺基]丁酸甲酯A60,作為起始材料使用5-(1,1,2,2,2-五氟乙基)吡啶-2-胺(實施例X) 4-sided oxo-4-[[5-(1,1,2,2,2-pentafluoroethyl)-2-pyridyl]amino]butyric acid methyl ester A60 , used as a starting material 5-- 1,1,2,2,2-pentafluoroethyl)pyridin-2-amine (Example X)
4-[(5-甲醯基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A76 4-[(5-Mexyl-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A76
將6-胺基-3-氰基吡啶(可商購的,1.0 g,8.40 mmol)溶解於四氫呋喃(20 mL)中,然後加入琥珀酸酸酐(1.04 g,10.5 mmol),將該混合物在100℃ 下攪拌12 h。停止該反應,並且將該溶液用碳酸鈉的飽和溶液洗滌。將該有機層在真空下濃縮。藉由快速層析法用甲醇-乙酸乙酯(5/95)洗提來純化該殘餘物,從而得到4-[(5-氰基-2-吡啶基)胺基]-4-側氧-丁酸A2(0.325 g,18%)。M.p.=220℃-221℃,1H NMR(400 MHz,DMSO-d6)δ 12.18(bs,1H),11.04(s,1H),8.78(s,1H),8.21(m,2H),2.69(t,2H),2.52(m,2H)ppm。LC-MS(方法B):RT 1.00,218(M-H+) 6-Amino-3-cyanopyridine (commercially available, 1.0 g, 8.40 mmol) was dissolved in tetrahydrofuran (20 mL) then succinic acid anhydride (1.04 g, 10.5 mmol). Stir at °C for 12 h. The reaction was stopped and the solution was washed with a saturated solution of sodium carbonate. The organic layer was concentrated under vacuum. The residue was purified by flash chromatography eluting with methanol-ethyl acetate (5/95) to give 4-[(5-cyano-2-pyridinyl) Butyric acid A2 (0.325 g, 18%). Mp = 220 ℃ -221 ℃, 1 H NMR (400 MHz, DMSO-d6) δ 12.18 (bs, 1H), 11.04 (s, 1H), 8.78 (s, 1H), 8.21 (m, 2H), 2.69 ( t, 2H), 2.52 (m, 2H) ppm. LC-MS (Method B): RT 1.00, 218 (MH + )
下面的來自表A的化合物係藉由同樣的方法製備的:4-[(5-溴-3-氯-2-吡啶基)胺基]-4-側氧-丁酸A13 The following compounds from Table A were prepared by the same procedure: 4-[(5-bromo-3-chloro-2-pyridyl)amino]-4-oxo-butyric acid A13
4-[(5-氰基-4,6-二甲基-2-吡啶基)胺基]-4-側氧-丁酸A14 4-[(5-Cyano-4,6-dimethyl-2-pyridyl)amino]-4-oxo-butyric acid A14
4-[(5-氰基-3-甲氧基-2-吡啶基)胺基]-4-側氧-丁酸A15 4-[(5-Cyano-3-methoxy-2-pyridyl)amino]-4-oxo-butyric acid A15
4-側氧-4-[[5-(三氟甲基)-2-吡啶基]胺基]丁酸A19 4-sided oxy-4-[[5-(trifluoromethyl)-2-pyridyl]amino]butyric acid A19
4-[(5-溴-6-甲基-2-吡啶基)胺基]-4-側氧-丁酸A21 4-[(5-bromo-6-methyl-2-pyridyl)amino]-4-oxo-butyric acid A21
4-[(5-溴-3-甲氧基-2-吡啶基)胺基]-4-側氧-丁酸A43 4-[(5-bromo-3-methoxy-2-pyridyl)amino]-4-oxo-butyric acid A43
4-[[5-溴-3-(三氟甲基)-2-吡啶基]胺基]-4-側氧-丁酸A45 4-[[5-bromo-3-(trifluoromethyl)-2-pyridinyl]amino]-4-oxo-butyric acid A45
4-[[3-氯-5-(三氟甲基)-2-吡啶基]胺基]-4-側氧-丁酸A47 4-[[3-chloro-5-(trifluoromethyl)-2-pyridyl]amino]-4-oxo-butyric acid A47
在環境溫度下將氫氧化鋰(0.058 g,1.0當量)加入到4-[(3-氰基-5-碘-2- 吡啶基)胺基]-4-側氧-丁酸甲酯(實施例I,A3,0.500 g,1.0當量)在四氫呋喃(15 mL)與水(5 mL)的混合物溶液中。將該反應混合物在室溫度下攪拌3 h。將殘餘物用碳酸氫鈉飽和溶液稀釋,並且用乙酸乙酯洗滌。該水相藉由添加鹽酸水溶液(濃縮的)酸化並且用乙酸乙酯萃取兩次。將合併的有機層在硫酸鎂上乾燥並在真空中濃縮,從而得到所希望的化合物A4(23.4%)。M.p.=215℃-218℃,1H NMR(400 MHz,DMSO-d6)δ 12.22(bs,1H),10.98(s,1H),8.96(s,1H),8.77(s,1H),2.72(t,2H),2.55(m,2H)ppm。LC-MS(方法A):RT 1.08,344(M-H+) Add lithium hydroxide (0.058 g, 1.0 eq.) to 4-[(3-cyano-5-iodo-2-pyridyl)amino]-4-oxo-butyric acid methyl ester at ambient temperature (implementation) Example I, A3 , 0.500 g, 1.0 eq.) in a mixture of tetrahydrofuran (15 mL) and water (5 mL). The reaction mixture was stirred at room temperature for 3 h. The residue was diluted with a saturated aqueous solution of sodium bicarbonate and washed with ethyl acetate. The aqueous phase was acidified by addition of aqueous hydrochloric acid (concentrated) and extracted twice with ethyl acetate. The combined organic layers were dried and concentrated in vacuo over magnesium sulfate to give the desired compound A4 (23.4%). Mp = 215 ℃ -218 ℃, 1 H NMR (400 MHz, DMSO-d6) δ 12.22 (bs, 1H), 10.98 (s, 1H), 8.96 (s, 1H), 8.77 (s, 1H), 2.72 ( t, 2H), 2.55 (m, 2H) ppm. LC-MS (Method A): RT 1.08, 344 (MH + )
下面的來自表A或者B的化合物係藉由同樣的方法製備的:4-側氧-4-[(3,5,6-三氯-2-吡啶基)胺基]丁酸A16 The following compounds from Table A or B were prepared by the same procedure: 4-oxo-4-[(3,5,6-trichloro-2-pyridyl)amino]butyric acid A16
4-[(3,5-二氯-2-吡啶基)胺基]-4-側氧-丁酸A17 4-[(3,5-Dichloro-2-pyridyl)amino]-4-oxo-butyric acid A17
4-[(3-溴-5-氯-2-吡啶基)胺基]-4-側氧-丁酸A18 4-[(3-bromo-5-chloro-2-pyridyl)amino]-4-oxo-butyric acid A18
4-側氧-4-[[5-[1,2,2,2-四氟-1-(三氟甲基)乙基]-2-吡啶基]胺基]丁酸A25 4-sided oxo-4-[[5-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-2-pyridyl]amino]butyric acid A25
4-[(5-溴-6-甲氧基-2-吡啶基)胺基]-4-側氧-丁酸A27 4-[(5-bromo-6-methoxy-2-pyridyl)amino]-4-oxo-butyric acid A27
4-[(5-甲基硫烷基-2-吡啶基)胺基]-4-側氧-丁酸A28 4-[(5-methylsulfanyl-2-pyridyl)amino]-4-oxo-butyric acid A28
4-[(5-氯-4-乙氧基-2-吡啶基)胺基]-4-側氧-丁酸A32 4-[(5-chloro-4-ethoxy-2-pyridyl)amino]-4-oxo-butyric acid A32
4-[(5-氰基-6-甲基-2-吡啶基)胺基]-4-側氧-丁酸A36 4-[(5-Cyano-6-methyl-2-pyridyl)amino]-4-oxo-butyric acid A36
4-[(5-氰基-2-吡啶基)胺基]-2,2-二甲基-4-側氧-丁酸B2 4-[(5-Cyano-2-pyridyl)amino]-2,2-dimethyl-4-oxo-butyric acid B2
4-[(5-溴-4-乙氧基-2-吡啶基)胺基]-4-側氧-丁酸A39 4-[(5-bromo-4-ethoxy-2-pyridyl)amino]-4-oxo-butyric acid A39
4-[(5-溴-6-氯-2-吡啶基)胺基]-4-側氧-丁酸A50 4-[(5-bromo-6-chloro-2-pyridyl)amino]-4-oxo-butyric acid A50
4-[(5-氯-4-甲氧基-2-吡啶基)胺基]-4-側氧-丁酸A61 4-[(5-chloro-4-methoxy-2-pyridyl)amino]-4-oxo-butyric acid A61
4-[(5-氯-6-甲氧基-2-吡啶基)胺基]-4-側氧-丁酸A62 4-[(5-chloro-6-methoxy-2-pyridyl)amino]-4-oxo-butyric acid A62
4-[(5-溴-4-甲氧基-2-吡啶基)胺基]-4-側氧-丁酸A63 4-[(5-bromo-4-methoxy-2-pyridinyl)amino]-4-oxo-butyric acid A63
4-側氧-4-[[5-(1,1,2,2,2-五氟乙基)-2-吡啶基]胺基]丁酸A64 4-sided oxo-4-[[5-(1,1,2,2,2-pentafluoroethyl)-2-pyridyl]amino]butyric acid A64
將4-側氧-4-[[5-(三氟甲基)-2-吡啶基]胺基]丁酸(實施例II,A19,50 mg,0.19 mmol)以及原甲酸三甲酯(60.7 mg,3當量)溶解於甲醇(4 mL)中,並滴加亞硫醯二氯(68.1 mg,3當量)。將該反應在室溫度下攪拌3 h。將溶劑蒸發並將該粗提物用Dowex 1×8 OH處理,從而得到4-側氧-4-[[5-(三氟甲基)-2-吡啶基]胺基]丁酸甲酯A20(36 mg,69%)。1H NMR(400 MHz,CDCl3):2.77(s,4H),3.73(s,3H),7.91(dd,1H),8.33(d,1H),8.54(s,1H),8.59(s,1H)。 4-Phenoxy-4-[[5-(trifluoromethyl)-2-pyridyl]amino]butyric acid (Example II, A19 , 50 mg, 0.19 mmol) and trimethyl orthoformate (60.7) Mg, 3 eq.) was dissolved in methanol (4 mL) and sulphur sulphur dichloride (68.1 mg, 3 eq.) was added dropwise. The reaction was stirred at room temperature for 3 h. The solvent was evaporated and the crude extract Dowex 1 × 8 OH treatment, to obtain side 4- oxo-4 - [[5- (trifluoromethyl) -2-pyridinyl] amino] butanoate A20 (36 mg, 69%). 1 H NMR (400 MHz, CDCl 3 ): 2.77 (s, 4H), 3.73 (s, 3H), 7.91 (dd, 1H), 8.33 (d, 1H), 8.54 (s, 1H), 8.59 (s, 1H).
將4-苄氧基-4-側氧-丁酸(可商購的,2.097 g,10.1 mmol,1.2當量)溶解於二氯甲烷,然後加入草醯二氯(2.13 g,1.4 mL,16.8 mmol,2.0當量) 以及一滴N,N-二甲基甲醯胺。將該溶液在室溫下攪拌1 h並且然後回流1 h。去除溶劑並且藉由真空乾燥。將殘餘物溶解於30 ml的四氫呋喃中,並在混合物中加入在的四氫呋喃(30 mL)以及吡啶(1.99 g,2.03 mL,25.2 mmol,3.0當量)中的6-胺基吡啶-3-腈(可商購的,1.00 g,8.39 mmol,1.0當量)。將該溶液回流4 h。停止該反應,並且將該溶液在乙酸乙酯與水之間分配。分離出水層並且用乙酸乙酯(2x)萃取。將合併的有機層在硫酸鎂上乾燥該並在真空中濃縮。藉由快速層析法用環己烷-乙酸乙酯(3/1)洗提來純化該殘餘物,從而得到4-[(5-氰基-2-吡啶基)胺基]-4-側氧-丁酸苄酯A23(2.49 g,96%)。LC-MS(方法A):RT 1.58,310(M-H+),308(M-H+)。 4-Benzyloxy-4-oxo-butyric acid (commercially available, 2.097 g, 10.1 mmol, 1.2 eq.) was dissolved in dichloromethane then EtOAc (2.sub.3 g, 1.4 mL, 16.8 mmol) , 2.0 equivalents) and one drop of N,N -dimethylformamide. The solution was stirred at room temperature for 1 h and then refluxed for 1 h. The solvent was removed and dried by vacuum. The residue was dissolved in 30 mL of THF (hexanes) (yield: THF (30 mL) and pyridine (1.99 g, 2.03 mL, 25.2 mmol, 3.0 eq.) of 6-aminopyridine-3-carbonitrile ( Commercially available, 1.00 g, 8.39 mmol, 1.0 eq.). The solution was refluxed for 4 h. The reaction was stopped and the solution was partitioned between ethyl acetate and water. The aqueous layer was separated and extracted with ethyl acetate (2×). The combined organic layers were dried over MgSO4 and concentrated in vacuo. The residue was purified by flash chromatography eluting with cyclohexane-ethyl acetate (3/1) to give 4-[(5-cyano-2-pyridyl)amino]-4- Benzyl oxy-butyrate A23 (2.49 g, 96%). LC-MS (Method A): RT 1.58, 310 (MH + ), 308 (MH + ).
向苯甲醇(3 mL)溶液中逐滴加入亞硫醯二氯(3當量,2.29 mmol,0.169 mL)。5 min後,向該溶液中加入4-側氧-4-[[5-(三氟甲基)-2-吡啶基]胺基]丁酸A19(如前所述製備的,201 mg,0.766 mmol)。將該反應混合物在室溫下攪拌過夜。停止該反應,並且將該溶液在乙酸乙酯和碳酸氫鈉的飽和溶液之間分配。分離出水層並且用乙酸乙酯(2x)萃取。將合併的有機層用水(x2)以及鹽水洗滌,在硫酸鎂上乾燥該並在真空中濃縮。加入水直到上述酯沈澱,以去除苯甲醇。過濾該酯並且然後用水以及環己烷(20 mL)洗滌。將該殘餘物首先溶解於乙酸乙酯中然後用環己烷沈澱並將所獲得的固體過濾,從而得到4-側氧-4-[[5-(三氟甲基)-2-吡啶基]胺基]丁酸苄酯A34(32%)。1H NMR(400 MHz,CDCl3)8.7(s,1H),8.31(m,1H),8.22(bs,1H),7.90(m,1H),7.35(m,5H),5.15(s,2H),2.78(m,4H)ppm。 Thionylene dichloride (3 equivalents, 2.29 mmol, 0.169 mL) was added dropwise to a solution of benzyl alcohol (3 mL). After 5 min, 4-sided oxy-4-[[5-(trifluoromethyl)-2-pyridyl]amino]butyric acid A19 (prepared as previously described, 201 mg, 0.766) was added to the solution. Mm). The reaction mixture was stirred at room temperature overnight. The reaction was stopped and the solution was partitioned between a saturated solution of ethyl acetate and sodium bicarbonate. The aqueous layer was separated and extracted with ethyl acetate (2×). The combined organic layers were washed with water (x2) and brine. Water was added until the above ester precipitated to remove benzyl alcohol. The ester was filtered and washed with water and hexanes (20 mL). The residue was first dissolved in ethyl acetate and then precipitated with cyclohexane and the obtained solid was filtered to give 4-y. Amino]benzyl butyrate A34 (32%). 1 H NMR (400 MHz, CDCl 3 ) 8.7 (s, 1H), 8.31 (m, 1H), 8.22 (bs, 1H), 7.90 (m, 1H), 7.35 (m, 5H), 5.15 (s, 2H) ), 2.78 (m, 4H) ppm.
來自表A的化合物A51、A52、A53、A54、A73、A74、A78、A79、A80以及A81係藉由同樣的方法用相對應的醇製備的。 Compounds A51, A52, A53, A54, A73, A74, A78, A79, A80 and A81 from Table A were prepared by the same method using the corresponding alcohol.
向4-[(5-溴-2-吡啶基)胺基]-4-側氧-丁酸甲酯(可商購的,0.25 g,0.871 mmol)在甲苯(10 mL)中的溶液內加入鈀、三苯基膦(0.101 g,0.0871 mmol)以及三丁基(乙烯基)錫烷(0.33 g,0.30 mL,1.04 mmol)。將該反應混合物回流過夜。然後,加入0.05 eq的鈀三苯基膦以及0.6 eq的三丁基(tutyl)乙烯基甲錫烷。在真空中去除揮發組分並且將殘餘物在乙腈中吸收(taken up)。將該乙腈相用己烷洗滌兩次並在真空中濃縮。藉由快速層析法用環己烷-乙酸乙酯(3/1)洗提來純化該殘餘物,從而得到4-側氧-4-[(5-乙烯基-2-吡啶基)胺基]丁酸甲酯(化合物A40)(0.20 g,15%)。1H NMR(400 MHz,CDCl3)8.26(s,1H),8.19(sb,1H),8.15(m,2H),7.76(m,1H),6.65(m,1H),5.34(d,1H),5.30(d,1H),3.72(s,3H),2.75(m,4H)ppm。 Add to a solution of 4-[(5-bromo-2-pyridinyl)amino]-4-oxo-butyric acid methyl ester (commercially available, 0.25 g, 0.871 mmol) in toluene (10 mL) Palladium, triphenylphosphine (0.101 g, 0.0871 mmol) and tributyl(vinyl)stannane (0.33 g, 0.30 mL, 1.04 mmol). The reaction mixture was refluxed overnight. Then, 0.05 eq of palladium triphenylphosphine and 0.6 eq of tutyl vinylstannane were added. The volatile components were removed in vacuo and the residue taken up in acetonitrile. The acetonitrile phase was washed twice with hexanes and concentrated in vacuo. The residue was purified by flash chromatography eluting with cyclohexane-ethyl acetate (3/1) to give 4-oxo-4-[(5-vinyl-2-pyridyl)amine. Methyl butyrate (Compound A40 ) (0.20 g, 15%). 1 H NMR (400 MHz, CDCl 3 ) 8.26 (s, 1H), 8.19 (sb, 1H), 8.15 (m, 2H), 7.76 (m, 1H), 6.65 (m, 1H), 5.34 (d, 1H) ), 5.30 (d, 1H), 3.72 (s, 3H), 2.75 (m, 4H) ppm.
向4-[(5-溴-2-吡啶基)胺基]-4-側氧-丁酸甲酯(可商購的,0.25 g,0.871 mmol)在四氫呋喃中的溶液內加入二(三苯基膦)二氯化鈀(II)(61.7536 mg,0.087 mmol)、碘化亞銅(I)(16.6 mg,0.087 mmol)、三乙胺(889 mg,1.23 mL,8.70 mmol)以及乙炔基三甲基矽烷(130 mg,0.19 mL,1.30 mmol)。將該反應混合物在65℃下攪拌過夜。停止該反應,並且將該溶液在乙酸乙酯與水之間分配。分離出水層並且用乙酸乙酯(2x)萃取。將合併的有機層在硫酸鎂上乾燥該並在真空中濃縮。藉由快速層析法用環己烷-乙酸乙酯(3/1)洗提來純化該殘餘物,從而得到4-側氧-4-[[5-(2-三甲基矽基乙炔基)-2-吡啶基]胺基]丁酸甲酯(26 mg,10%產率)。1H NMR(400 MHz,CDCl3)8.39(s,1H),8.14(m,2H),7.74(d,1H),3.72(s,3H),2.74(m,4H),0.24(s,9H)ppm。 To a solution of 4-[(5-bromo-2-pyridinyl)amino]-4-oxo-butyric acid methyl ester (commercially available, 0.25 g, 0.871 mmol) in tetrahydrofuran, bis(triphenylbenzene) Palladium (II) (61.7536 mg, 0.087 mmol), copper (I) iodide (16.6 mg, 0.087 mmol), triethylamine (889 mg, 1.23 mL, 8.70 mmol) and ethynyl Methyl decane (130 mg, 0.19 mL, 1.30 mmol). The reaction mixture was stirred at 65 ° C overnight. The reaction was stopped and the solution was partitioned between ethyl acetate and water. The aqueous layer was separated and extracted with ethyl acetate (2×). The combined organic layers were dried over MgSO4 and concentrated in vacuo. The residue was purified by flash chromatography eluting with cyclohexane-ethyl acetate (3/1) to afford 4-y. Methyl-2-pyridyl]amino]butyrate (26 mg, 10% yield). 1 H NMR (400 MHz, CDCl 3 ) 8.39 (s, 1H), 8.14 (m, 2H), 7.74 (d, 1H), 3.72 (s, 3H), 2.74 (m, 4H), 0.24 (s, 9H) )ppm.
向4-側氧-4-[[5-(2-三甲基矽基乙炔基)-2-吡啶基]胺基]丁酸甲酯(26 mg,0.085 mmol)在甲醇中的溶液內一次性加入碳酸鉀(5.90 mg,0.042 mmol)並且將該反應混合物在室溫下攪拌2 h。停止該反應,並且將該溶液在乙酸乙酯與水之間分配。分離出水層並且用乙酸乙酯(2x)萃取。將合併的有機層在硫酸鎂上乾燥該並在真空中濃縮,從而得到4-[(5-乙炔基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A41(12 mg,60%產率)。1H NMR(400 MHz,CDCl3)8.39(d,1H),8.16(m,2H),7.77(d,1H),3.72(s,3H),2.74(m,4H)ppm。 To a solution of methyl 4-oxo-4-[[5-(2-trimethyldecylethynyl)-2-pyridyl]amino]butanoate (26 mg, 0.085 mmol) in methanol Potassium carbonate (5.90 mg, 0.042 mmol) was added and the mixture was stirred at room temperature for 2 h. The reaction was stopped and the solution was partitioned between ethyl acetate and water. The aqueous layer was separated and extracted with ethyl acetate (2×). The combined organic layers were dried over magnesium sulfate and concentrated in vacuo to give 4 - [(5-ethynyl-2-pyridyl) amino] -4-oxo-side - butyric acid methyl ester A41 (12 mg , 60% yield). 1 H NMR (400 MHz, CDCl 3 ) 8.39 (d, 1 H), 8.16 (m, 2H), 7.77 (d, 1H), 3.72 (s, 3H), 2.74 (m, 4H) ppm.
向2-胺基吡啶(25.0 g,263 mmol)在水(250 ml)以及三級丁基甲基醚(25 ml)的混合物的溶液中,相繼地加入全氟乙基碘(80 g,38 ml,315 mmol)、亞硫酸氫鈉(64.6 g,26 ml,315 mmol)、碳酸氫鈉(26.5 g,315.6 mmol) 以及四丁基硫酸氫銨(“TBAHS”)(0.11當量,9.92 g,28.9 mmol)。將該反應混合物在環境溫度下攪拌16 h。過濾該混合物並將濾液用三級丁基甲基醚萃取兩次。將合併的有機相相繼地用水、鹽酸水溶液(1 N)以及鹽水洗滌,在硫酸鈉上乾燥並濃縮。將該殘餘物藉由快速層析法(乙酸乙酯/環己烷)純化,從而得到5-(1,1,2,2,2-五氟乙基)吡啶-2-胺,產率為7%。1H NMR(400 MHz,CDCl3)8.23(d,1H),7.61(d,1H),6.72(m,1H),5.04(sb,2H,NH2)ppm。主要的副產物係3,5-二(1,1,2,2,2-五氟乙基)吡啶-2-胺。 To a solution of a mixture of 2-aminopyridine (25.0 g, 263 mmol) in water (250 ml) and tris-butylmethyl ether (25 ml), EtOAc (80 g, 315 mmol), sodium bisulfite (64.6 g, 26 ml, 315 mmol), sodium bicarbonate (26.5 g, 315.6 mmol) and tetrabutylammonium hydrogen sulfate ("TBAHS") (0.11 equivalent, 9.92 g, 28.9 mmol) ). The reaction mixture was stirred at ambient temperature for 16 h. The mixture was filtered and the filtrate was extracted twice with tri-n-butyl methyl ether. The combined organic phases were washed sequentially with water, aq. The residue was purified by flash chromatography (ethyl acetate /hexane) to give 5-(1,1,2,2,2-pentafluoroethyl)pyridin-2-amine 7%. 1 H NMR (400 MHz, CDCl 3 ) 8.23 (d, 1H), 7.61 (d, 1H), 6.72 (m, 1H), 5.04 (sb, 2H, NH 2 ) ppm. The main by-product is 3,5-di(1,1,2,2,2-pentafluoroethyl)pyridin-2-amine.
將4-[(5-氰基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A1(0.200 g,0.857 mmol)、疊氮化鈉(0.169 g,0.09 mL,2.57 mmol)以及三乙基氯化銨(0.187 g,0.17 ml,1.33 mmol)的混合物在1-甲基-2-吡咯啶酮(10 mL)中在150℃下攪拌4 h。 4-[(5-Cyano-2-pyridyl)amino]-4-oxo-butyric acid methyl ester A1 (0.200 g, 0.857 mmol), sodium azide (0.169 g, 0.09 mL, 2.57 mmol) A mixture of triethylammonium chloride (0.187 g, 0.17 ml, 1.33 mmol) was stirred in 1-methyl-2-pyrrolidone (10 mL) at 150 ° C for 4 h.
將該混合物冷卻下來並用水稀釋。用鹽酸水溶液(1 N)酸化之後,將濾液用乙酸乙酯萃取兩次。將該有機相組合,在硫酸鈉上乾燥並進行濃縮。將該殘餘物懸浮於乙酸乙酯中並過濾,從而得到4-側氧-4-[[5-(1H-四氮唑-5-基)-2-吡啶基]胺基]丁酸甲酯A65(0.06 g,25%產率)。M.p.:246℃-248℃,LC-MS(方法F):RT 0.53,277(M+H+)。 The mixture was cooled down and diluted with water. After acidification with aqueous hydrochloric acid (1 N), the filtrate was extracted twice with ethyl acetate. The organic phases were combined, dried over sodium sulfate and concentrated. The residue was suspended in ethyl acetate and filtered to give 4-yt-oxy-4-[[5-(1H-tetraazol-5-yl)-2-pyridinyl]amino]butyric acid methyl ester A65 (0.06 g, 25% yield). Mp: 246 ° C - 248 ° C, LC-MS (Method F): RT 0.53, 277 (M+H + ).
向丁-1-醇(3 mL)溶液中滴加亞硫醯二氯(2.73 mmol,0.200 mL,3 eq)。5 min後,向該溶液中加入4-[(5-氰基-2-吡啶基)胺基]-4-側氧-丁酸A2(如前所述製備的,200 mg,0.912 mmol)。將該反應混合物在室溫下攪拌過夜。停止該反應,並且將該溶液在乙酸乙酯與水之間分配。分離出水層並且用乙酸乙酯(2x)萃取。將合併的有機層用碳酸氫鈉的飽和溶液洗滌並在硫酸鎂上乾燥,然後在真空中濃縮。該殘餘物首先用環己烷洗滌,並將所得的固體藉由快速層析法用環己烷-乙酸乙酯洗提來純化,從而得到4-[(5-氰基-2-吡啶基)胺基]-4-側氧-丁酸丁酯A66(10%)以及副產物6-[(4-丁氧基-4-側氧-丁醯基)胺基]吡啶-3-羧酸丁酯A67(9%)。 Thionylene dichloride (2.73 mmol, 0.200 mL, 3 eq) was added dropwise to a solution of butan-1-ol (3 mL). After 5 min, 4-[(5-cyano-2-pyridinyl)amino]-4-oxo-butyric acid A2 (prepared as above, 200 mg, 0.912 mmol) was added to this solution. The reaction mixture was stirred at room temperature overnight. The reaction was stopped and the solution was partitioned between ethyl acetate and water. The aqueous layer was separated and extracted with ethyl acetate (2×). The combined organic layers were washed with a saturated aqueous solution of sodium bicarbonate and dried over magnesium sulfate. The residue was first washed with cyclohexane, and the obtained solid was purified by flash chromatography eluting with hexane-ethyl acetate to afford 4-[(5- cyano-2-pyridyl) Amino]-4-oxo-butyl butyrate A66 (10%) and by-product 6-[(4-butoxy-4-oxo-butanyl)amino]pyridine-3-carboxylic acid butyl ester A67 (9%).
4-[(5-氰基-2-吡啶基)胺基]-4-側氧-丁酸丁酯A66;LC-MS(方法F)RT 0.89,276(M+H+)。 4-[(5-Cyano-2-pyridinyl)amino]-4-oxo-butyric acid butyl ester A66 ; LC-MS (Method F) RT 0.89, 276 (M+H + ).
6-[(4-丁氧基-4-側氧-丁醯基)胺基]吡啶-3-羧酸丁酯A67;LC-MS(方法F)RT 01.10,351(M+H+)。 6-[(4-Butoxy-4-oxo-butanyl)amino]pyridine-3-carboxylic acid butyl ester A67 ; LC-MS (Method F) RT: 0.11, 351 (M+H + ).
向4-[(5-氰基-2-吡啶基)胺基]-4-側氧-丁酸A2(如前所述製備的,200 mg,0.857 mmol,1當量)在乙腈(5 mL)中的溶液內加入碘甲烷(10當量,8.57 mmol,0.534 mL)以及氫化鈉(1當量,0.857 mmol,0.037 mL)。將該反應混合物在室溫下攪拌過夜。次日,加入1當量的氫化鈉(34.3 mg)以提高產物的量值並將該混合物在室溫下攪拌1 h。停止該反應,並且將該溶液在乙酸乙酯與水之間分配。分離出水層並且用乙酸乙酯(2x)萃取。將合併的有機層在硫酸鎂上乾燥,並且然後在真空中濃縮。將所得的固體藉由快速層析法用環己烷-乙酸乙酯洗提來純化,並且然後溶解於乙酸乙酯中並且用環己烷進行沈澱。用冰/水冷卻後,將該沈澱的固體過濾並且得到4-[(5-氰基-2-吡啶基)-甲基-胺基]-4-側氧-丁酸甲酯A68(45%)。1H NMR(400 MHz,CDCl3)8.69(s,1H),7.90(m,2H),3.71(s,3H),3.52(s,3H),2.92(m,2H),2.71(m,2H)ppm。 To 4-[(5-Cyano-2-pyridyl)amino]-4-oxo-butyric acid A2 (prepared as above, 200 mg, 0.857 mmol, 1 eq.) in acetonitrile (5 mL) Methyl iodide (10 equivalents, 8.57 mmol, 0.534 mL) and sodium hydride (1 eq, 0.857 mmol, 0.037 mL) were added to the solution. The reaction mixture was stirred at room temperature overnight. The next day, 1 equivalent of sodium hydride (34.3 mg) was added to increase the amount of product and the mixture was stirred at room temperature for 1 h. The reaction was stopped and the solution was partitioned between ethyl acetate and water. The aqueous layer was separated and extracted with ethyl acetate (2×). The combined organic layers were dried over magnesium sulfate and then concentrated in vacuo. The obtained solid was purified by flash chromatography eluting with cyclohexane-ethyl acetate, and then dissolved in ethyl acetate and precipitated with cyclohexane. After cooling with ice/water, the precipitated solid was filtered to give 4-[(5-cyano-2-pyridyl)-methyl-amino]-4-oxo-butyric acid methyl ester A68 (45%) ). 1 H NMR (400 MHz, CDCl 3 ) 8.69 (s, 1H), 7.90 (m, 2H), 3.71 (s, 3H), 3.52 (s, 3H), 2.92 (m, 2H), 2.71 (m, 2H) )ppm.
來自表A的化合物A69係藉由同樣的方法用相對應的烷化劑製備的。 Compound A69 from Table A was prepared by the same method using the corresponding alkylating agent.
將4-[(5-甲醯基-2-吡啶基)胺基]-4-側氧-丁酸甲酯A76(0.09 g,0.381 mmol,1當量)在甲苯(6 mL)中的懸浮液在去氧-氟(50質量%)的存在下在80℃加熱過夜。停止該反應,並且將該溶液在乙酸乙酯與水之間分配。分離出水層並且用乙酸乙酯(2x)萃取。將合併的有機層在硫酸鎂上乾燥,並且然後在真空中濃縮。將所得的固體藉由快速層析法(FC)用梯度環己烷-乙酸乙酯洗提來純化,從而得到4-[[5-(二氟甲基)-2-吡啶基]胺基]-4-側氧-丁酸甲酯A77(52%)。LC-MS(方法F):RT 0.71,259(M+H+)。 A suspension of methyl 4-[(5-methylamido-2-pyridinyl)amino]-4-oxo-butyric acid A76 (0.09 g, 0.381 mmol, 1 eq.) in toluene (6 mL) It was heated at 80 ° C overnight in the presence of deoxy-fluorine (50% by mass). The reaction was stopped and the solution was partitioned between ethyl acetate and water. The aqueous layer was separated and extracted with ethyl acetate (2×). The combined organic layers were dried over magnesium sulfate and then concentrated in vacuo. The obtained solid was purified by flash chromatography (FC) eluting with gradient cyclohexane-ethyl acetate to give 4-[[5-(difluoromethyl)-2-pyridinyl]amino] -4- Side Oxygen-butyric acid methyl ester A77 (52%). LC-MS (Method F): RT 0.71, 259 (M+H + ).
在微波管中裝入4-[(5-溴-2-吡啶基)胺基]-4-側氧-丁酸甲酯(可商購的或用如在實施例II中所描述的,起始材料用可商購的5-溴2-胺基吡啶:200 mg,0.696 mmol,1當量製備的)、2-噻吩基硼酸(3當量,2.09 mmol,3當量)、二 (三-三級丁基膦)鈀(0)(22 mg,0.043 mmol,0.06當量)、碳酸鉀(179 mg,1.28 mmol,1.8當量)並溶解於乙二醇二甲醚(5 ml)/水(2ml)中。在微波下將反應混合物在130℃下加熱20分鐘。停止該反應,並且將該溶液在乙酸乙酯與鹼性水之間分配。分離出水層並且用乙酸乙酯(2x)萃取。將合併的有機層在硫酸鎂上乾燥,並且然後在真空中濃縮。將所得的固體藉由快速層析法用梯度環己烷-乙酸乙酯洗提來純化,從而得到4-側氧-4-[[5-(2-噻吩基)-2-吡啶基]胺基]-丁酸甲酯A71(8%)。%)。LC-MS(方法F):RT 0.85,291(M+H+)。 The microwave tube is charged with 4-[(5-bromo-2-pyridinyl)amino]-4-oxo-butyric acid methyl ester (commercially available or as described in Example II) The starting material was commercially available 5-bromo 2-aminopyridine: 200 mg, 0.696 mmol, 1 equivalent of prepared, 2-thienylboronic acid (3 equivalents, 2.09 mmol, 3 equivalents), two (three-three grades) Butyl phosphine) palladium (0) (22 mg, 0.043 mmol, 0.06 eq.), potassium carbonate (179 mg, 1.28 mmol, 1.8 eq.) and dissolved in dimethyl ether (5 ml) / water (2 ml) . The reaction mixture was heated at 130 ° C for 20 minutes under microwave. The reaction was stopped and the solution was partitioned between ethyl acetate and basic water. The aqueous layer was separated and extracted with ethyl acetate (2×). The combined organic layers were dried over magnesium sulfate and then concentrated in vacuo. The obtained solid was purified by flash chromatography eluting with gradient cyclohexane-ethyl acetate to give 4-oxo-4-[[5-(2-thienyl)-2-pyridinyl]amine Methyl]-butyric acid A71 (8%). %). LC-MS (Method F): RT 0.85, 291 (M+H + ).
將該水層用氯化氫酸化直至pH 1-2,並且用乙酸乙酯(2x)萃取。將合併的有機層在硫酸鎂上乾燥,並且然後在真空中濃縮。將該固體用乙酸乙酯洗滌,過濾並且乾燥,從而得到4-側氧-4-[[5-(2-噻吩基)-2-吡啶基]胺基]丁酸A72(31%產率)。%)。LC-MS(方法F):RT 0.74,277(M+H+)。 The aqueous layer was acidified with hydrogen chloride to pH 1-2 and extracted with ethyl acetate (2×). The combined organic layers were dried over magnesium sulfate and then concentrated in vacuo. The solid was washed with ethyl acetate, filtered and dried to give 4-t-[upta][sup.sup.sup.sup.[[5-(2-thienyl)-2-pyridinyl]amino]butyric acid A72 (31% yield) . %). LC-MS (Method F): RT 0.74, 277 (M+H + ).
在80℃下,向碳酸氫鈉(1.81 g,21.4 mmol,5當量)以及鹽酸羥胺(1.50 g,21.4 mmol,5當量)在水(12 mL)中的溶液裡加入4-[(5-氰基-2-吡啶基)胺基]-4-側氧-丁酸A2(1.00 g,4.29 mmol,1當量)在甲醇(120 mL)中的溶液。在真空下濃縮之前,將該溶液加熱至80℃過夜。將該殘餘物在乙酸乙酯(50 mL)與水(50 mL)之間分配。分離出水層並且用乙酸乙酯(3×50 ml)萃取。將合併的有機層在硫酸鎂上乾燥,並且然後在真空中濃縮,從而得到760 mg的粗產物。在藉由快速層析法用梯度甲醇以及二氯甲烷(0至10%在甲醇中)洗提純化之前,將該粗產物吸附在isolute上,從而得到4-[[5-[(Z)-N'-羥基甲脒基]-2-吡啶基]胺基]-4-側氧-丁酸甲酯(0.46 g,1.73 mmol,40%產率)。 Add 4-[(5-cyanide) to a solution of sodium bicarbonate (1.81 g, 21.4 mmol, 5 eq.) and hydroxylamine hydrochloride (1.50 g, 21.4 mmol, 5 eq.) in water (12 mL). A solution of benzyl-2-pyridyl)amino]-4-oxo-butyric acid A2 (1.00 g, 4.29 mmol, 1 eq.) in methanol (120 mL). The solution was heated to 80 ° C overnight before concentration under vacuum. The residue was partitioned between EtOAc (50 mL)EtOAc. The aqueous layer was separated and extracted with ethyl acetate (3×50 ml). The combined organic layers were dried over magnesium sulfate and then concentrated in vacuo to afford 760 mg of crude. The crude product was adsorbed onto the isolute by flash chromatography eluting with gradient methanol and dichloromethane (0 to 10% in methanol) to give 4-[[5-[(Z)- Methyl N'-hydroxymethylindenyl]-2-pyridinyl]amino]-4-oxo-butyrate (0.46 g, 1.73 mmol, 40% yield).
向4-[[5-[(Z)-N'-羥基甲脒基]-2-吡啶基]胺基]-4-側氧-丁酸甲酯(如在步驟1中說明的獲得的,0.15 g,0.56 mmol,1當量)在二氯甲烷(30 mL)的懸浮液中加入乙酸酐(1.98 mL,20.3 mmol,36當量)。在真空下濃縮之前,將該混合物攪拌5天,得到4-[[5-[(Z)-N'-乙醯氧基甲脒基]-2-吡啶基]胺基]-4- 側氧-丁酸甲酯,將其不需要額外的純化的用於下一步驟。 To 4-[[5-[(Z)-N'-hydroxymethylindenyl]-2-pyridyl]amino]-4-oxo-butyric acid methyl ester (as obtained in step 1, Acetic anhydride (1.98 mL, 20.3 mmol, 36 eq.) was added to a suspension of dichloromethane (30 mL). The mixture was stirred for 5 days before concentration under vacuum to give 4-[[5-[(Z)-N'-acetoxymethoxymethyl]-2-pyridyl]amino]-4- The side oxy-butyric acid methyl ester was used in the next step without additional purification.
在室溫下,向4-[[5-[(Z)-N'-乙醯氧基甲脒基]-2-吡啶基]胺基]-4-側氧-丁酸甲酯(在步驟2中獲得的,0.18 g,0.58 mmol,1當量)在四氫呋喃(20 mL)中的溶液內加入在THF(0.053 g,0.058 mL,0.058 mmol,0.1當量)中的四丁基氟化銨(1.0 mol/L)。將混合物在室溫下攪拌4 h。將該殘餘物在乙酸乙酯與水之間分配。分離出水層並且用乙酸乙酯(3×50 ml)萃取。將合併的有機層在硫酸鎂上乾燥,並且然後在真空中濃縮。將殘餘物藉由快速層析法用梯度乙酸乙酯以及環己烷洗提來純化,從而得到4-[[5-(5-甲基-1,2,4-二唑-3-基)-2-吡啶基]胺基]-4-側氧-丁酸甲酯A75(0.062 g,37%產率)。LC-MS(方法F):RT 0.72,291(M+H+)。 4-[[5-[(Z)-N'-Ethyloxymethylindenyl]-2-pyridinyl]amino]-4-oxo-butyric acid methyl ester (at the step) To a solution of tetrabutylammonium fluoride (0.13 g, 0.058 mL, 0.058 mmol, 0.1 eq. Mol/L). The mixture was stirred at room temperature for 4 h. The residue was partitioned between ethyl acetate and water. The aqueous layer was separated and extracted with ethyl acetate (3×50 ml). The combined organic layers were dried over magnesium sulfate and then concentrated in vacuo. The residue was purified by flash chromatography eluting with gradient ethyl acetate and cyclohexane to afford 4-[[5-(5-methyl-1,2,4- Moxazol-3-yl)-2-pyridinyl]amino]-4-oxo-butyric acid methyl ester A75 (0.062 g, 37% yield). LC-MS (Method F): RT 0.72, 291 (M+H + ).
在微波小管中將4-[(5-溴-2-吡啶基)胺基]-4-側氧-丁酸甲酯(可商購的或用如在實施例II中所描述的,起始材料用可商購的5-溴2-胺基吡啶:200 mg,0.697 mmol製備的)溶解於甲苯中,並且加入3-吡啶基三丁基錫烷(0.836 mmol,0.290 mL)以及四(三苯基膦)鈀(0)(0.069 mmol)。將氬氣鼓泡穿過該混合物約5 min,並且在150℃下將該小瓶在微波輻射下加熱10 min。將溶劑蒸發,並將該殘餘物用乙腈稀釋,用環己烷(2x)洗滌並蒸發。將產物藉由快速層析法(RF-設備,乙酸乙酯/環己烷:0/100->100/0)純化,從而得到4-側氧-4-[[5-(3-吡啶基)-2-吡啶基]胺基]丁酸甲酯(化合物A82)(0.051 g,26%產率)。LC-MS(方法F):RT 0.50,286(M+H+)。 4-[(5-Bromo-2-pyridinyl)amino]-4-oxo-butyric acid methyl ester (commercially available or as described in Example II) in a microwave vial The material was dissolved in toluene with commercially available 5-bromo-2-aminopyridine: 200 mg, 0.697 mmol), and 3-pyridyltributylstannane (0.836 mmol, 0.290 mL) and tetrakis(triphenyl) were added. Phosphine) palladium (0) (0.069 mmol). Argon was bubbled through the mixture for about 5 min and the vial was heated under microwave irradiation for 10 min at 150 °C. The solvent was evaporated and the residue was diluted with EtOAc EtOAc (EtOAc) The product was purified by flash chromatography (RF-EtOAc, EtOAc/EtOAc/EtOAc/EtOAc/EtOAc/EtOAc Methyl-2-pyridyl]amino]butyrate (Compound A82 ) (0.051 g, 26% yield). LC-MS (Method F): RT 0.50, 286 (M+H + ).
來自表A的化合物A83,A84以及A85係藉由同樣的方法使用相應的偶合劑製備的。 Compounds A83 , A84 and A85 from Table A were prepared by the same method using the corresponding coupling agents.
進行了兩種生物測定以便於測定本發明的化合物的活性。在第一測定中,該化合物的活性係在豆中基於其對第二片葉子的葉柄的伸長的作用進行定量的。在第二個測定中,確定了該化合物對小麥的根生長的作用。 Two biological assays were performed to facilitate determination of the activity of the compounds of the invention. In the first assay, the activity of the compound is quantified in the bean based on its effect on the elongation of the petiole of the second leaf. In the second assay, the effect of the compound on root growth of wheat was determined.
將法國豆(菜豆)的品種富爾維奧(Fulvio)播種在0.5升的花盆中的砂質壤土中,無需額外的肥料。植物在溫室條件下,在22℃/18℃(日/夜)以及80%的相對濕度下生長;光補償超過25 kLux。 Fulvio, a French bean (Nut. bean) variety, is sown in sandy loam in a 0.5 liter pot without the need for additional fertilizer. Plants were grown under greenhouse conditions at 22 ° C / 18 ° C (day / night) and 80% relative humidity; light compensation exceeded 25 kLux.
播種十一天之後,當第二個節間的長為2-5 mm時,用試驗化合物處理植物。在施用之前,該化合物各自溶解於二甲亞碸中,並在羊毛脂油與丙酮(按體積計,比率1:2)的混合物中稀釋。用移液管吸取五微升的試驗化合物到第二個節間的基部切除苞片葉之後形成的傷口處。施用十四天 後,測定第二片葉子的葉柄的長度(從葉柄基部到第一片小葉的基部測量),以量化該化合物的活性。 After eleven days of sowing, when the second internode length was 2-5 mm, the plants were treated with the test compound. Prior to application, the compounds were each dissolved in dimethyl hydrazine and diluted in a mixture of lanolin oil and acetone (by volume, ratio 1:2). Pipette five microliters of test compound to the wound formed after the base of the second internode to remove the bract leaf. Fourteen days of application Thereafter, the length of the petiole of the second leaf (measured from the base of the petiole to the base of the first leaflet) was determined to quantify the activity of the compound.
下列化合物給出了至少10%的第二片葉子的葉柄長度的增加: A19、A2、A1、A4、A23、A31、A32、A38、A39、A52、A54、B2。 The following compounds give an increase in the length of the petiole of at least 10% of the second leaf: A19, A2, A1, A4, A23, A31, A32, A38, A39, A52, A54, B2.
將試驗化合物溶解於少量體積的二甲亞碸中,並且用水稀釋至適當的濃度。將小麥(普通小麥)品種阿裡娜(Arina)的種子播種在微型小袋(10.5 ×9.0 cm)中,該袋中包含有5 mL的適當的化合物溶液。將該微型小袋在17℃下貯藏3天以使得該等種子能夠萌發。然後將植株貯藏在5℃。播種/施用12天後,將植物從微型小袋中移出並進行掃描。該化合物的作用係藉由確定植物(根以及嫩枝)的面積以及根的捲曲(捲曲係油菜素內酯型活性的指標)來量化的。 The test compound was dissolved in a small volume of dimethyl hydrazine and diluted with water to the appropriate concentration. The seeds of the wheat (common wheat) variety Arina were sown in a mini pouch (10.5 x 9.0 cm) containing 5 mL of the appropriate compound solution. The mini pouch was stored at 17 ° C for 3 days to enable the seeds to germinate. The plants were then stored at 5 °C. After 12 days of sowing/administration, the plants were removed from the micro pouch and scanned. The action of this compound was quantified by determining the area of the plants (roots and shoots) and the curl of the roots (an indicator of the activity of the coiled brassinolide type).
下列化合物減少了至少15%的植物(根以及嫩枝)面積,並顯示了捲曲的根的表型: A19、A2、A1、A22、A31、A32、A38、A39、A52、A54。 The following compounds reduced the area of plants (roots and shoots) by at least 15% and showed the phenotype of the curled roots: A19, A2, A1, A22, A31, A32, A38, A39, A52, A54.
Claims (10)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11018163 | 2011-09-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201326124A true TW201326124A (en) | 2013-07-01 |
Family
ID=49224752
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW101133662A TW201326124A (en) | 2011-09-16 | 2012-09-14 | Plant growth regulating compounds |
TW101133660A TW201329052A (en) | 2011-09-16 | 2012-09-14 | Plant growth regulating compounds |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW101133660A TW201329052A (en) | 2011-09-16 | 2012-09-14 | Plant growth regulating compounds |
Country Status (1)
Country | Link |
---|---|
TW (2) | TW201326124A (en) |
-
2012
- 2012-09-14 TW TW101133662A patent/TW201326124A/en unknown
- 2012-09-14 TW TW101133660A patent/TW201329052A/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW201329052A (en) | 2013-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9345244B2 (en) | Plant growth regulating compounds | |
US9241489B2 (en) | Plant growth regulating compounds | |
US10399950B2 (en) | Substituted amino azoles as plant growth regulators | |
AU2016307240A1 (en) | Plant growth regulator compounds | |
JP2018517699A (en) | Plant growth regulating compounds | |
US10392348B2 (en) | 2-oxo-3,4-dihydroquinoline compounds as plant growth regulators | |
TW201326124A (en) | Plant growth regulating compounds | |
TW201339136A (en) | Plant growth regulating compounds | |
WO2013164245A1 (en) | Plant growth regulating compounds | |
TW201442629A (en) | Plant growth regulating compounds | |
WO2014131732A2 (en) | Plant growth regulating compounds |